Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3027923	s-c-pept	nmol/l (nmol/l)	929	1203	0.00%
3027923	p-c-pept	nmol/l (nmol/l)	784	1586	0.00%
3027923	p-c-pept	— (—)	327	428	100.00%	Distribution not available
3027923	s-c-pept	— (—)	226	255	100.00%	Distribution not available
3027923	p-c-peptidi	nmol/l (nmol/l)	36	39	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diabetes mellitus

1361

306

27.09

307.65

1.4

2.7

1.20

1.47

nmol/l

3.84

1064

266

Diabetes, insulin treatment (Kela reimbursement)

1421

376

23.63

307.65

1.3

2.3

1.15

1.54

nmol/l

7.44

1101

320

Type 2 diabetes, strict (exclude DM1)

1114

282

24.02

307.65

1.4

2.3

1.36

1.42

nmol/l

0.45

877

241

Type 1 diabetes, wide definition, subgroup 1

267

32.94

307.65

1.5

2.8

0.51

1.57

nmol/l

14.90

198

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1379

267

32.27

307.65

1.3

2.4

1.15

1.44

nmol/l

4.01

1067

230

Diabetes medication

1377

352

24.27

307.65

1.4

2.4

1.19

1.46

nmol/l

4.06

1075

302

Insulin medication

1267

251

44.85

307.65

1.4

2.2

1.00

1.50

nmol/l

8.81

959

210

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

500

157

33.36

307.65

1.3

1.8

1.34

1.37

nmol/l

0.09

375

127

Endocrine, nutritional and metabolic diseases

621

160

19.95

307.65

1.7

2.3

1.22

1.47

nmol/l

1.96

488

136

Other (not insulin) diabetes medications

1267

317

24.60

307.65

1.4

2.2

1.25

1.48

nmol/l

2.70

990

269

Sulfonylureas

488

154

25.98

307.65

1.3

1.4

0.95

1.31

nmol/l

2.81

360

125

Insulin, fast-acting or short human

725

579

12.99

307.65

1.4

1.6

0.79

1.43

nmol/l

27.96

552

454

Insulin, combination of fast acting with intermediate-acting or long-acting

1267

600

20.20

307.65

1.4

1.7

1.00

1.53

nmol/l

21.70

959

491

Biguanides

1227

427

18.07

307.65

1.4

2.0

1.27

nmol/l

0.02

960

350

Type 2 diabetes

1306

280

28.28

307.65

1.4

2.5

1.25

1.46

nmol/l

2.31

1017

241

Other blood glucose lowering drugs, excl. Insulins

281

32.46

307.65

1.3

1.5

1.09

1.24

nmol/l

0.50

223

Insulin, intermediate and long-acting

1210

564

21.94

307.65

1.4

1.7

0.97

1.53

nmol/l

23.17

911

464

Combinations of oral blood glucose lowering drugs

419

173

25.04

307.65

1.3

1.6

1.20

1.26

nmol/l

0.25

340

137

Type 2 diabetes, definitions combined

1112

258

26.20

307.65

1.4

2.4

1.36

1.43

nmol/l

0.50

876

221

Type 2 diabetes, wide definition

1089

259

28.06

307.65

1.3

2.0

1.23

1.26

nmol/l

0.15

840

222

Type 1 diabetes, wide definition

275

32.71

307.65

1.5

2.8

0.53

1.54

nmol/l

14.74

206

Insulin, fast-acting

721

366

20.47

307.65

1.4

1.8

0.79

1.53

nmol/l

25.35

549

301

Glucagon-like peptide-1 (GLP-1) analogues

848

283

25.42

307.65

1.3

1.6

1.24

1.29

nmol/l

0.25

644

228

Type 2 diabetes, definitions combined, including avohilmo

1108

263

25.40

307.65

1.4

2.5

1.36

1.45

nmol/l

0.61

870

230

Type 1 diabetes

339

35.07

307.65

1.5

2.8

0.61

1.52

nmol/l

14.27

254

Diabetes, varying definitions

1347

315

26.07

307.65

1.5

2.7

1.20

1.44

nmol/l

3.22

1055

272

Dipeptidyl peptidase 4 (DPP-4) inhibitors

159

30.47

241.44

1.3

1.4

1.16

1.33

nmol/l

0.35

122

Sub-endpoint used in defining T1D endpoints

352

526

6.71

218.63

1.5

1.6

0.60

1.36

nmol/l

29.42

265

412

Obesity due to excess calories

408

835

4.96

185.79

2.1

1.5

1.61

1.13

nmol/l

10.45

316

661

Other nutritional deficiencies

504

1189

4.19

185.04

1.9

1.5

1.57

1.14

nmol/l

10.41

394

939

Obesity and other hyperalimentation

490

1161

4.22

182.62

1.9

1.5

1.60

1.13

nmol/l

11.59

377

925

Obesity

488

1157

4.22

181.93

1.9

1.5

1.60

1.13

nmol/l

11.53

375

922

Special screening examination for other diseases and disorders

147

17.48

178.51

1.4

0.96

1.23

nmol/l

1.45

122

Any reimbursement code in KELA

306

180

8.57

164.40

1.6

3.5

1.25

1.73

nmol/l

4.64

241

164

Continuous positive airway pressure

115

22.80

142.57

1.7

2.1

1.62

1.52

nmol/l

0.21

Cardiac arrhythmias

228

188

8.06

138.25

1.6

2.8

1.19

1.56

nmol/l

3.56

190

169

Hypertensive diseases (excluding secondary)

377

456

4.85

136.47

1.6

1.8

1.27

1.25

nmol/l

0.11

293

375

Hypertension, essential

494

739

3.84

135.04

1.5

1.7

1.22

1.21

nmol/l

0.07

385

590

Hypertension

499

754

3.77

132.69

1.5

1.7

1.22

1.21

nmol/l

0.06

392

603

Hypertensive diseases

499

755

3.77

132.51

1.5

1.7

1.22

1.21

nmol/l

0.08

392

604

Statin medication

426

572

4.21

129.50

1.5

1.8

1.20

1.22

nmol/l

0.12

328

465

Chronic pancreatitis

159

217

7.54

110.20

1.4

1.3

0.79

1.21

nmol/l

4.73

123

164

Elevated blood glucose level

127

132

9.97

109.76

1.6

1.3

1.10

1.20

nmol/l

0.32

107

102

Metabolic disorders

577

1234

2.92

108.16

1.5

1.22

1.24

nmol/l

0.17

449

985

Medical observation and evaluation for suspected diseases and conditions

400

571

3.61

96.68

1.7

1.6

1.28

1.23

nmol/l

0.28

264

481

Obesity, other/unspecified

241

555

4.39

95.13

2.1

1.6

1.62

1.10

nmol/l

7.10

184

443

Disorders of lipoprotein metabolism and other lipidaemias

499

1075

2.94

94.78

1.4

1.25

1.22

nmol/l

0.16

378

855

Other disorders of glucose regulation and pancreatic internal secretion

112

134

8.60

86.79

2.4

1.4

1.19

1.28

nmol/l

0.24

103

Pure hypercholesterolaemia

435

989

2.97

86.02

1.5

1.4

1.27

1.24

nmol/l

0.21

334

780

Neurological diseases, wide definition

143

10.31

85.94

1.6

3.2

1.31

1.44

nmol/l

0.37

118

Disorders of gallbladder, biliary tract and pancreas

550

1394

2.56

81.56

1.6

1.5

1.17

1.28

nmol/l

1.40

450

1075

Cardiovascular diseases (excluding rheumatic etc)

346

591

3.40

80.69

1.7

2.1

1.22

1.29

nmol/l

0.46

269

487

Sleep disorders (combined)

544

1422

2.52

78.82

1.6

1.45

1.17

nmol/l

5.58

406

1151

Other retinal disorders

378

1029

2.97

78.80

1.4

0.89

1.29

nmol/l

11.26

260

819

Sleep apnoea

515

1371

2.56

77.85

1.6

1.5

1.47

1.17

nmol/l

5.96

381

1102

Sleep apnoea, including avohilmo

526

1396

2.46

72.23

1.6

1.5

1.47

1.15

nmol/l

6.68

390

1124

Autoimmune diseases excluding thyroid diseases

560

1282

2.44

72.18

1.5

1.6

1.00

1.38

nmol/l

11.71

433

1021

Hypoglycaemia, other or unspecified

106

8.84

72.09

2.6

1.5

1.24

1.28

nmol/l

0.08

General examination and investigation of persons without complaint and reported diagnosis

341

570

3.20

70.63

1.6

1.31

1.23

nmol/l

0.48

267

480

Autoimmune diseases excluding thyroid diseases, strict definition

544

1250

2.44

70.26

1.5

1.6

1.00

1.38

nmol/l

11.08

424

996

Acute pancreatitis

162

352

4.67

69.04

1.4

1.3

0.90

1.21

nmol/l

3.40

130

269

Heart failure, not strict

415

1075

2.68

68.76

1.4

1.40

1.17

nmol/l

2.90

310

841

Nerve, nerve root and plexus disorders

555

1534

2.28

64.42

1.5

1.6

1.23

1.26

nmol/l

0.22

434

1208

Autoimmune diseases

574

1285

2.29

63.32

1.6

1.00

1.39

nmol/l

12.01

438

1024

Acute pancreatitis (for exclusion)

162

388

4.24

61.05

1.4

1.3

0.90

1.21

nmol/l

3.55

130

301

Insulin, fast-acting (human)

123

7.32

60.88

1.7

2.0

0.52

1.59

nmol/l

12.99

101

Abnormalities of breathing

478

1195

2.39

60.41

1.5

1.7

1.34

1.21

nmol/l

1.41

367

947

Used for control exclusion in common control thyroid runs

542

1212

2.28

58.88

1.5

1.6

1.05

1.38

nmol/l

7.98

415

969

Antihypertensive medication - note that there are other indications

277

476

3.20

58.05

1.8

2.1

1.46

1.22

nmol/l

2.21

220

401

Implicit Sepsis

380

1183

2.51

57.29

1.4

1.5

1.33

1.21

nmol/l

1.08

296

935

Disorders of choroid and retina

417

1262

2.42

57.19

1.4

1.5

0.93

1.31

nmol/l

10.82

291

1002

Heart failure and antihypertensive medication

135

171

5.26

56.67

1.5

1.51

1.17

nmol/l

1.46

135

Other special examinations and investigations of persons without complaint or reported diagnosis

324

571

2.88

55.90

1.5

1.6

1.08

1.23

nmol/l

1.40

260

481

Cardiovascular diseases

286

521

3.00

54.22

1.7

2.1

1.27

1.32

nmol/l

0.23

222

429

Alcohol-induced chronic pancreatitis

123

6.86

52.31

1.4

0.81

1.21

nmol/l

2.51

Diseases of oesophagus, stomach and duodenum

525

1509

2.12

50.87

1.6

1.24

1.25

nmol/l

0.09

407

1198

STROKE

234

529

3.08

50.19

1.4

1.5

1.15

1.39

nmol/l

2.56

183

427

Persons encountering health services for specific procedures and health care

520

1540

2.10

49.32

1.5

1.6

1.20

1.27

nmol/l

0.60

408

1217

Type 1 diabetes, strict definition

14.31

48.35

2.2

3.7

0.34

1.81

nmol/l

9.88

Renal failure

237

765

2.85

47.68

1.4

1.3

1.37

1.17

nmol/l

1.49

175

584

Other disorders of fluid, electrolyte and acid-base balance

166

464

3.48

47.20

1.4

1.3

1.19

1.18

nmol/l

0.02

124

365

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

457

1450

2.15

47.14

1.6

1.25

1.27

nmol/l

0.14

340

1163

Other heart diseases

218

463

3.13

47.11

1.6

1.8

1.15

1.24

nmol/l

0.55

170

379

Condition for Implicit Sepsis (Organ dysfunction codes)

409

1339

2.23

46.75

1.4

1.6

1.31

1.24

nmol/l

0.58

319

1056

Type 1 diabetes, strict definition, subgroup 1

14.60

46.67

2.2

3.7

0.34

1.84

nmol/l

9.27

Other diseases of pancreas

119

6.54

46.52

1.4

0.89

1.24

nmol/l

1.83

Other bacterial diseases

452

1489

2.11

44.51

1.4

1.5

1.20

1.25

nmol/l

0.38

337

1188

Persons encountering health services for examination and investigation

300

571

2.64

44.38

1.7

1.6

1.27

1.23

nmol/l

0.20

223

481

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

460

1590

2.08

44.26

1.5

1.6

1.24

1.26

nmol/l

0.14

356

1252

Renal tubulo-interstitial diseases

403

1435

2.16

43.37

1.4

1.6

1.29

1.25

nmol/l

0.29

306

1132

Codeine

461

1206

2.11

42.95

1.6

1.30

1.27

nmol/l

0.23

360

981

Codeine or tramadol medication

538

1534

1.95

40.75

1.6

1.31

1.23

nmol/l

0.82

422

1219

Episodal and paroxysmal disorders

504

1299

1.99

39.91

1.7

1.6

1.28

1.20

nmol/l

0.92

381

1053

Gestational diabetes (for exclusion)

170

373

3.24

39.90

2.6

2.0

1.42

1.35

nmol/l

0.29

150

311

Chronic kidney disease

158

496

3.20

39.67

1.5

1.3

1.43

1.16

nmol/l

1.54

113

382

Hypertensive heart and/or renal disease

122

239

3.98

39.61

1.4

1.3

0.99

1.21

nmol/l

1.46

184

Implicit bacterial Sepsis

198

647

2.82

39.30

1.3

1.32

1.15

nmol/l

1.03

156

501

Diabetes mellitus in pregnancy

151

281

3.51

38.72

2.3

2.2

1.36

1.37

nmol/l

0.04

131

239

Disorders of thyroid, IBD co-morbidities

9.15

38.70

1.8

3.3

1.18

1.62

nmol/l

1.26

Glomerular disorders in diseases classified elsewhere

202

4.58

38.00

1.7

1.4

1.22

1.19

nmol/l

0.05

152

Cerebrovascular diseases (FINNGEN)

144

299

3.47

37.54

1.4

1.5

1.15

1.29

nmol/l

0.67

111

242

Diseases of arteries, arterioles and capillaries (FINNGEN)

120

214

3.95

37.15

1.4

1.12

1.23

nmol/l

0.51

169

Hypertensive Heart Disease

109

223

4.03

36.56

1.4

1.3

1.01

1.22

nmol/l

1.23

170

Neurological diseases

390

927

2.12

36.30

1.6

1.7

1.28

1.19

nmol/l

0.78

294

758

Fitting and adjustment of other devices

173

558

2.90

36.29

1.4

1.3

1.20

nmol/l

0.01

131

425

Bacterial Sepsis

216

746

2.59

36.11

1.3

1.4

1.29

1.17

nmol/l

0.70

167

582

Abnormal findings on examination of blood, without diagnosis

245

950

2.43

36.10

1.4

1.21

1.25

nmol/l

0.23

207

716

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

413

1282

2.03

36.00

1.4

1.7

1.32

1.22

nmol/l

0.80

315

1018

413

1282

2.03

36.00

1.4

1.7

1.32

1.22

nmol/l

0.80

315

1018

Influenza and pneumonia

472

1619

1.92

35.94

1.4

1.7

1.30

1.23

nmol/l

0.51

368

1285

Tramadol

362

1107

2.11

35.34

1.5

1.25

nmol/l

0.01

265

896

Explicit Sepsis

202

747

2.61

34.80

1.4

1.5

1.20

1.18

nmol/l

0.05

147

584

Mood disorders, excluding more controls

429

1328

1.97

34.53

1.6

1.32

1.24

nmol/l

0.77

318

1069

Acute renal failure

119

347

3.46

34.04

1.3

1.38

1.17

nmol/l

0.98

260

Concussion

222

778

2.48

33.81

1.6

1.7

1.27

1.20

nmol/l

0.36

164

640

Opioids

448

1212

1.95

33.51

1.7

1.6

1.20

1.27

nmol/l

0.64

342

985

All pneumoniae

447

1630

1.90

33.18

1.4

1.6

1.30

1.22

nmol/l

0.67

342

1296

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

183

413

2.82

33.06

1.4

1.8

1.26

nmol/l

0.00

133

338

Diseases of liver

186

712

2.63

32.91

1.4

1.32

1.19

nmol/l

0.72

145

550

Gastro-oesophageal reflux disease

306

1277

2.13

32.90

1.6

1.5

1.29

1.24

nmol/l

0.29

230

1001

Presence of other devices

119

355

3.38

32.80

1.5

1.3

1.10

1.18

nmol/l

0.33

102

273

Pneumonias (Asthma/COPD co-morbidities)

442

1627

1.89

32.31

1.4

1.6

1.30

1.22

nmol/l

0.68

338

1293

Intracranial trauma

247

791

2.34

32.15

1.5

1.7

1.23

1.20

nmol/l

0.15

186

652

Septicaemia

193

735

2.54

31.57

1.3

1.5

1.17

1.22

nmol/l

0.31

138

569

Other septicaemia

177

661

2.64

31.56

1.3

1.4

1.19

1.23

nmol/l

0.18

126

507

Other soft tissue disorders, not elsewhere classified

399

1267

1.95

31.36

1.6

1.13

1.29

nmol/l

2.30

301

1010

Symptoms and signs involving the digestive system and abdomen

458

1223

1.88

30.73

1.5

1.16

1.26

nmol/l

1.09

350

969

Cholelithiasis, broad definition with cholecystitis

360

1243

1.99

30.70

1.7

1.5

1.28

1.29

nmol/l

0.05

295

953

Secondary hypertension

6.51

30.67

1.5

1.3

1.42

1.31

nmol/l

0.18

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

428

1622

1.86

30.02

1.4

1.6

1.31

1.22

nmol/l

0.84

324

1290

Atrial fibrillation and flutter with reimbursement

117

216

3.49

29.85

1.4

1.3

1.15

1.24

nmol/l

0.38

168

Peripheral artery disease

213

721

2.39

29.53

1.3

1.11

1.21

nmol/l

0.67

153

559

Abdominal and pelvic pain

452

1223

1.86

29.49

1.6

1.5

1.15

1.26

nmol/l

1.20

353

969

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

144

4.73

29.20

1.3

0.89

1.25

nmol/l

2.59

104

Carpal tunnel syndrome

265

1122

2.14

29.02

1.5

1.23

1.26

nmol/l

0.21

204

878

Implicit viral Sepsis

104

310

3.38

28.81

1.5

1.4

1.43

1.14

nmol/l

1.49

237

Viral Sepsis

104

310

3.38

28.81

1.5

1.4

1.43

1.14

nmol/l

1.49

237

Mood disorders

449

1632

1.81

28.65

1.6

1.34

1.23

nmol/l

1.15

335

1310

Infections of the skin and subcutaneous tissue

267

1270

2.10

28.40

1.5

1.6

1.18

1.22

nmol/l

0.24

190

1010

Parasetamol

349

890

2.01

28.33

1.7

1.6

1.33

1.20

nmol/l

1.10

273

707

Follow-up examination after treatment for conditions other than malignant neoplasms

170

417

2.68

28.32

1.9

1.6

1.18

1.23

nmol/l

0.22

125

359

Mood [affective] disorders

447

1631

1.81

28.32

1.6

1.34

1.22

nmol/l

1.28

334

1308

Dialysis, with operation codes

211

3.93

28.28

1.7

1.4

1.26

1.19

nmol/l

0.18

159

Glomerular diseases

110

345

3.22

28.10

1.6

1.4

1.37

1.19

nmol/l

0.62

267

Cholelithiasis

339

1215

1.96

27.97

1.7

1.5

1.30

1.28

nmol/l

0.10

277

933

Mouth breathing

209

913

2.30

27.78

1.4

1.5

1.37

1.19

nmol/l

1.46

173

698

Other disorders of skin and subcutaneous tissue, not elsewhere classified

243

3.66

27.43

1.6

1.4

1.14

1.22

nmol/l

0.24

189

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

262

3.55

27.41

1.3

1.18

1.13

nmol/l

0.16

201

Obesity related asthma

173

701

2.48

27.30

1.6

1.42

1.25

nmol/l

1.08

138

548

Care involving use of rehabilitation procedures

279

1303

2.04

27.22

1.5

1.20

1.27

nmol/l

0.53

238

1024

Care involving dialysis

133

4.74

27.11

1.9

1.4

1.34

1.18

nmol/l

0.34

106

Oxycodone

168

652

2.51

26.87

1.3

1.16

1.27

nmol/l

0.62

120

517

Dyspnoea

373

1540

1.86

26.75

1.6

1.5

1.41

1.23

nmol/l

1.80

275

1220

Diseases of pulp and periapical tissues

173

708

2.46

26.72

1.8

1.5

1.30

1.24

nmol/l

0.25

128

573

Dentinal caries

127

443

2.87

26.69

1.6

1.5

1.40

1.18

nmol/l

1.09

352

Depression

410

1561

1.81

26.54

1.7

1.6

1.33

1.22

nmol/l

1.01

304

1257

Alcohol-induced acute pancreatitis

6.75

26.49

1.4

1.5

0.82

1.22

nmol/l

1.49

Other diseases of intestines

455

1494

1.77

26.45

1.6

1.23

1.26

nmol/l

0.18

363

1175

Disorders of lens

301

943

2.02

26.31

1.3

1.4

1.26

nmol/l

0.01

218

740

Pain in throat and chest

359

1158

1.90

26.19

1.5

1.6

1.29

1.19

nmol/l

0.74

281

916

Ischaemic heart disease, wide definition

339

1101

1.93

26.15

1.3

1.4

1.21

1.22

nmol/l

0.06

264

848

Symptoms and signs involving the circulatory and respiratory systems

433

1200

1.81

26.05

1.7

1.24

1.21

nmol/l

0.26

347

949

Other functional intestinal disorders

195

808

2.31

25.98

1.5

1.12

1.23

nmol/l

0.83

159

630

Nutritional anaemias

204

882

2.26

25.97

1.6

1.5

1.24

1.22

nmol/l

0.09

160

682

Transplanted organ and tissue status

157

4.26

25.35

1.9

1.4

1.27

1.19

nmol/l

0.20

122

Pneumonia, organism unspecified

378

1502

1.83

25.28

1.4

1.6

1.30

1.21

nmol/l

0.70

276

1184

Dental caries

136

504

2.69

25.26

1.5

1.6

1.39

1.22

nmol/l

0.79

104

403

Other and unspecified iron deficiency

146

568

2.58

25.10

1.6

1.5

1.30

1.22

nmol/l

0.33

113

440

Soft tissue disorders

438

1282

1.78

25.03

1.7

1.6

1.14

1.29

nmol/l

2.01

349

1022

Pain in limb

322

1222

1.91

24.84

1.5

1.6

1.11

1.29

nmol/l

2.31

241

976

Other intervertebral disc disorders

370

1232

1.84

24.67

1.5

1.6

1.22

1.28

nmol/l

0.45

288

976

Iron deficiency anaemia

174

733

2.36

24.65

1.5

1.30

1.20

nmol/l

0.46

133

574

Nonalcoholic fatty liver disease

170

4.06

24.48

1.4

1.5

1.79

1.22

nmol/l

2.12

135

Atrial fibrillation and flutter

129

294

2.88

24.48

1.4

1.5

1.12

1.27

nmol/l

0.95

104

238

Factors influencing health status and contact with health services

143

254

2.84

24.29

1.4

1.5

1.22

1.18

nmol/l

0.16

105

212

Certain infectious and parasitic diseases

422

1188

1.78

24.11

1.6

1.7

1.20

1.26

nmol/l

0.49

319

971

Psychiatric diseases

461

1333

1.74

24.06

1.5

1.6

1.18

1.24

nmol/l

0.50

351

1072

Bacterial infection, other or unspecified

221

940

2.13

23.99

1.4

1.20

1.24

nmol/l

0.21

165

730

Other symptoms and signs involving the nervous and musculoskeletal systems

189

844

2.25

23.96

1.7

1.6

1.15

1.23

nmol/l

0.64

162

665

Other and unspecified polyneuropathies, also in other diseases

105

353

3.00

23.91

1.4

1.3

1.22

1.21

nmol/l

0.04

273

Any mental disorder

469

1366

1.72

23.87

1.5

1.6

1.21

1.24

nmol/l

0.22

357

1098

Amputation

156

4.15

23.80

1.5

1.3

1.05

1.10

nmol/l

0.17

118

Erysipelas

240

1071

2.05

23.71

1.4

1.28

1.23

nmol/l

0.25

174

833

Depression or dysthymia

306

881

1.95

23.60

1.7

1.5

1.21

1.22

nmol/l

0.10

227

720

Other antidepressants

440

1321

1.74

23.50

1.5

1.24

nmol/l

0.01

330

1079

Diseases of pulp and periapical tissues, including avohilmo

443

1327

1.74

23.45

1.7

1.6

1.28

1.25

nmol/l

0.18

337

1043

Shoulder lesions

334

1098

1.87

23.24

1.5

1.4

1.25

1.26

nmol/l

0.03

258

870

Ischemic heart diseases

334

1126

1.86

23.17

1.3

1.4

1.21

1.22

nmol/l

0.05

260

869

General symptoms and signs

469

1379

1.71

23.17

1.6

1.24

nmol/l

0.02

362

1104

Anxiety disorders, excluding more controls

338

1217

1.85

23.10

1.6

1.24

1.23

nmol/l

0.02

248

981

Fibrosis and cirrhosis of liver

123

4.54

22.91

1.3

1.19

1.12

nmol/l

0.22

Coronary atherosclerosis

291

973

1.94

22.76

1.4

1.19

1.20

nmol/l

0.08

221

748

Complications of surgical and medical care, not elsewhere classified

405

1682

1.73

22.71

1.6

1.19

1.28

nmol/l

0.90

310

1329

Alcohol use disorder, Swedish definition

258

1223

1.97

22.70

1.5

1.08

1.26

nmol/l

1.94

195

967

Diseases of the eye and adnexa

358

979

1.84

22.50

1.7

1.17

1.34

nmol/l

1.71

281

806

Dental pulpitis 1

440

1332

1.72

22.49

1.7

1.6

1.28

1.25

nmol/l

0.17

336

1046

Dental pulpitis 4

440

1332

1.72

22.48

1.7

1.6

1.28

1.25

nmol/l

0.17

336

1046

Fall on same level

481

1617

1.67

22.25

1.5

1.6

1.17

1.28

nmol/l

1.43

363

1302

Polyneuropathies and other disorders of the peripheral nervous system

112

406

2.78

22.25

1.4

1.3

1.21

nmol/l

0.01

314

Cirrhosis of liver, NAS

5.16

22.19

1.3

1.19

1.08

nmol/l

0.31

Polycystic ovarian syndrome, consortium definition

257

774

2.01

22.01

1.9

1.8

1.33

1.32

nmol/l

0.04

201

628

Substance abuse, excluding more controls

245

1085

1.98

21.90

1.4

1.6

1.12

1.24

nmol/l

1.05

183

874

Disorder of lipoprotein metabolism, unspecified

198

3.62

21.89

1.3

1.16

1.23

nmol/l

0.17

152

Peripheral arterial reconstruction

273

3.18

21.63

1.4

1.3

1.04

1.16

nmol/l

0.42

204

Other diseases of liver

321

2.98

21.48

1.4

1.55

1.17

nmol/l

1.71

249

Ulcer of lower limb, not elsewhere classified

241

3.31

21.23

1.5

1.3

1.06

1.24

nmol/l

0.76

181

Peripheral artery operations in Hilmo

198

3.57

21.12

1.5

1.3

1.13

1.17

nmol/l

0.10

150

Pure hyperglyceridaemia

8.69

21.11

1.7

1.4

1.23

1.02

nmol/l

0.29

GASTRO-related operations

323

875

1.86

21.07

1.8

1.5

1.24

1.26

nmol/l

0.16

245

711

Any gastric operation

323

875

1.86

21.07

1.8

1.5

1.24

1.26

nmol/l

0.16

245

711

Diseases of arteries, arterioles and capillaries

276

1090

1.90

21.01

1.4

1.14

1.24

nmol/l

0.78

205

840

Cholecystectomy

280

1330

1.87

21.00

1.8

1.5

1.30

1.24

nmol/l

0.38

237

1015

Other and unspecified nerve root and plexus disorders, also in other diseases

336

2.91

20.99

1.2

1.4

1.34

1.21

nmol/l

0.51

257

Heart failure,strict

211

734

2.08

20.74

1.4

1.3

1.43

1.14

nmol/l

2.10

151

566

Other disorders of skin and subcutaneous tissue

275

1354

1.87

20.74

1.4

1.5

1.23

1.25

nmol/l

0.11

213

1057

Other dorsopathies, not elsewhere classified

423

1321

1.69

20.58

1.7

1.19

1.29

nmol/l

1.11

331

1052

Senile cataract

259

827

1.95

20.55

1.3

1.4

1.28

1.27

nmol/l

0.01

187

648

Presence of cardiac and vascular implants and grafts

190

671

2.15

20.54

1.3

1.25

1.22

nmol/l

0.12

140

520

261

1272

1.89

20.49

1.4

1.5

1.07

1.27

nmol/l

2.42

198

1005

271

1305

1.87

20.35

1.4

1.5

1.08

1.27

nmol/l

2.29

206

1033

Nausea and vomiting

113

425

2.63

20.16

1.3

1.6

1.35

1.24

nmol/l

0.36

337

Hard cardiovascular diseases

327

1176

1.79

20.16

1.3

1.4

1.24

1.21

nmol/l

0.17

254

909

L04AD Calcineurin inhibitors

197

3.49

19.86

1.9

1.4

1.27

1.22

nmol/l

0.14

152

Atherosclerosis, excluding cerebral and coronary sclerosis

178

659

2.17

19.85

1.4

1.3

1.14

1.20

nmol/l

0.30

130

510

Familial hypercholesterolemia

232

3.26

19.73

1.3

1.2

1.10

1.20

nmol/l

0.28

179

Persons encountering health services in other circumstances, wide

492

1591

1.61

19.61

1.7

1.6

1.28

1.24

nmol/l

0.30

393

1245

ILD medications

466

1582

1.62

19.41

1.6

1.24

1.23

nmol/l

0.03

359

1264

Cellulitis

109

420

2.61

19.28

1.4

1.5

1.10

1.20

nmol/l

0.46

322

Dental pulpitis 4, only avohilmo

438

1391

1.65

19.24

1.7

1.6

1.26

1.25

nmol/l

0.10

339

1090

Dental pulpitis 1, only avohilmo

439

1396

1.65

19.20

1.7

1.6

1.26

1.25

nmol/l

0.07

339

1095

Dorsalgia

406

1317

1.67

19.09

1.6

1.7

1.17

1.29

nmol/l

1.36

313

1050

Complications of procedures, not elsewhere classified

322

1613

1.73

18.73

1.7

1.6

1.20

1.29

nmol/l

0.67

250

1274

ILD medications: prednisolone, methylprednisolone, prednisone

448

1570

1.62

18.60

1.6

1.28

1.23

nmol/l

0.32

345

1255

Cutaneous abscess, furuncle and carbuncle

121

499

2.44

18.57

1.6

1.17

1.27

nmol/l

0.39

395

Myocardial infarction

214

777

1.99

18.53

1.3

1.30

1.18

nmol/l

0.70

167

583

Disorders of other endocrine glands

177

842

2.08

18.43

1.7

1.69

1.18

nmol/l

4.83

143

655

Malignant neoplasm of pancreas

4.68

18.23

1.3

0.90

0.98

nmol/l

0.33

Chronic periapical parodontitis

103

398

2.61

18.15

1.8

1.5

1.34

1.21

nmol/l

0.52

314

COPD/asthma related infections

420

1284

1.64

18.06

1.5

1.7

1.25

1.23

nmol/l

0.15

327

1020

COPD/asthma/ILD related infections

420

1284

1.64

18.06

1.5

1.7

1.25

1.23

nmol/l

0.15

327

1020

Myocardial infarction, strict

200

734

2.00

17.69

1.3

1.29

1.18

nmol/l

0.56

156

552

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

242

1318

1.84

17.63

1.5

1.13

1.24

nmol/l

0.88

186

1026

Chronic periodontitis, including avohilmo

363

1628

1.65

17.47

1.4

1.5

1.36

1.21

nmol/l

1.57

283

1281

Headache

254

1172

1.82

17.41

1.9

1.6

1.35

1.23

nmol/l

0.86

197

935

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

161

361

2.24

17.40

1.6

1.7

1.26

1.20

nmol/l

0.28

130

283

Hernia of abdominal wall, postoperative

299

2.83

17.37

1.5

1.3

1.26

nmol/l

0.01

240

Other pulmonary diagnosis

337

982

1.72

17.34

1.6

1.27

1.21

nmol/l

0.39

268

777

Parodontitis and operation codes

346

1617

1.67

17.34

1.5

1.36

1.21

nmol/l

1.61

271

1274

Mixed hyperlipidaemia

5.71

17.30

1.2

1.3

1.24

1.05

nmol/l

0.34

Other dialysis

6.32

17.26

2.3

1.5

1.04

1.11

nmol/l

0.09

Functional dyspepsia

114

474

2.42

17.22

1.8

1.6

1.41

1.24

nmol/l

0.73

100

381

Falls/tendency to fall

448

1412

1.59

17.09

1.5

1.7

1.19

1.28

nmol/l

0.96

335

1147

Parodontitis or operation codes

363

1630

1.64

17.08

1.4

1.5

1.36

1.21

nmol/l

1.58

282

1283

Aplastic and other anaemias

176

829

2.02

16.97

1.3

1.4

1.30

1.22

nmol/l

0.35

131

640

Parodontitis

362

1631

1.64

16.87

1.4

1.5

1.36

1.21

nmol/l

1.58

282

1283

Nephropathy related operations

224

3.11

16.84

1.9

1.4

1.20

1.14

nmol/l

0.14

174

Pain in joint

230

813

1.88

16.75

1.9

1.5

1.37

1.27

nmol/l

0.62

178

654

Menorrhagia

136

322

2.35

16.71

1.9

1.8

1.24

1.23

nmol/l

0.03

104

256

Unspecified urinary incontinence

134

3.77

16.44

1.6

1.3

1.33

1.23

nmol/l

0.18

105

Other/unspecified dorsalgia

156

749

2.08

16.43

1.7

1.6

1.21

1.28

nmol/l

0.35

122

587

Amputation of toe

112

4.07

16.40

1.6

1.3

1.00

1.03

nmol/l

0.08

Vitreous haemorrhage

177

3.37

16.39

1.8

1.4

0.87

1.20

nmol/l

1.54

134

Symptoms and signs involving the nervous and musculoskeletal systems

225

1232

1.83

16.34

1.6

1.16

1.23

nmol/l

0.53

187

956

Other disorders of teeth and supporting structures

101

408

2.49

16.28

1.6

1.4

1.20

1.21

nmol/l

0.00

322

Excluding asthma or asthma-COPD overlap

332

982

1.70

16.24

1.5

1.6

1.27

1.21

nmol/l

0.40

260

777

Anxiety disorders

354

1542

1.63

16.06

1.6

1.22

1.26

nmol/l

0.28

259

1243

First line medication for Crohn's disease

443

1548

1.56

16.04

1.6

1.21

1.24

nmol/l

0.21

352

1229

Gout, unspecified

364

2.57

16.03

1.2

1.3

1.74

1.08

nmol/l

4.97

279

Asthma, unspecified (mode), excluding more controls

197

806

1.92

16.02

1.5

1.7

1.27

1.19

nmol/l

0.46

154

641

All-cause Heart Failure

224

873

1.86

16.00

1.3

1.42

1.19

nmol/l

1.60

161

664

Recurrent or chronic depression

162

566

2.07

15.94

1.6

1.7

1.58

1.25

nmol/l

2.44

117

465

Neurotic, stress-related and somatoform disorders

350

1529

1.63

15.90

1.6

1.7

1.22

1.25

nmol/l

0.24

256

1235

Acute tubulo-interstitial nephritis

224

1090

1.83

15.89

1.5

1.6

1.25

nmol/l

0.02

172

863

Chronic ulcer of skin, not elsewhere classified

106

4.11

15.88

1.6

1.3

1.08

1.15

nmol/l

0.12

Diarrhoea and gastroenteritis of presumed infectious origin

275

1459

1.72

15.82

1.5

1.6

1.23

nmol/l

0.04

200

1171

Selective serotonin reuptake inhibitors

401

1323

1.60

15.81

1.7

1.5

1.27

1.23

nmol/l

0.24

299

1081

Angina pectoris

237

882

1.82

15.75

1.3

1.22

1.17

nmol/l

0.24

189

671

Complications of medical and surgical care

278

1551

1.71

15.74

1.5

1.6

1.16

1.27

nmol/l

0.88

210

1218

Substance abuse

245

1330

1.77

15.68

1.4

1.6

1.12

1.25

nmol/l

1.12

183

1055

Other cataract

167

643

2.02

15.51

1.4

1.32

1.28

nmol/l

0.18

121

499

Diseases of the ear and mastoid process

467

1541

1.54

15.41

1.6

1.24

1.27

nmol/l

0.20

368

1226

Hypothyroidism, strict autoimmune

262

993

1.75

15.28

1.7

1.14

1.39

nmol/l

2.98

201

795

Heart failure, strict

225

891

1.82

15.25

1.3

1.42

1.19

nmol/l

1.68

161

681

Mental and behavioural disorders due to psychoactive substance use

248

1346

1.74

15.18

1.4

1.6

1.11

1.25

nmol/l

1.24

186

1067

Familial hypercholesterolemia, with ischemic heart disease

137

3.61

15.17

1.2

1.3

1.05

nmol/l

0.00

104

Other heart diseases, wide

362

1401

1.61

15.10

1.6

1.21

1.25

nmol/l

0.28

280

1116

Other and unspecified anaemias

157

759

2.01

15.01

1.3

1.4

1.25

1.21

nmol/l

0.19

116

580

Excessive, frequent and irregular menstruation

143

366

2.18

14.98

1.9

1.33

1.24

nmol/l

0.30

106

293

Chronic gastritis

110

480

2.30

14.96

1.3

1.05

1.21

nmol/l

0.85

374

Other CVD (FINNGEN)

3.92

14.94

1.4

1.2

1.05

1.32

nmol/l

0.84

Asthma, excluding more controls

292

913

1.71

14.91

1.6

1.7

1.20

1.19

nmol/l

0.02

235

732

Asthma, unspecified (mode)

201

859

1.86

14.81

1.5

1.6

1.28

1.21

nmol/l

0.38

158

672

Gastrointestinal diseases

225

610

1.85

14.78

1.7

1.6

1.30

nmol/l

0.01

176

494

COPD differential diagnosis

326

986

1.66

14.75

1.5

1.6

1.26

1.21

nmol/l

0.28

257

779

ILD differential diagnosis

326

986

1.66

14.75

1.5

1.6

1.26

1.21

nmol/l

0.28

257

779

Major coronary heart disease event excluding revascularizations

259

1034

1.73

14.74

1.3

1.30

1.18

nmol/l

0.85

201

788

Lumbar disc prolapse

254

1173

1.73

14.60

1.5

1.26

nmol/l

0.03

201

930

Diabetic nephropathy, excluding more controls

168

722

1.97

14.56

1.6

1.4

1.08

1.29

nmol/l

1.62

126

567

Other maternal disorders predominantly related to pregnancy

190

626

1.91

14.55

1.9

1.8

1.31

1.35

nmol/l

0.21

161

498

Presence of other functional implants

204

782

1.85

14.54

1.4

1.3

1.09

1.24

nmol/l

0.97

134

615

Other anaemias

157

766

1.98

14.53

1.3

1.4

1.25

1.21

nmol/l

0.20

116

586

Myocardial infarction, without ST-elevation

158

737

1.99

14.53

1.3

1.26

1.19

nmol/l

0.30

119

562

Hypo-osmolality and hyponatraemia

254

2.80

14.52

1.3

1.18

1.21

nmol/l

0.10

197

Substance use, excluding alcohol

376

2.46

14.52

1.3

1.7

1.12

1.29

nmol/l

0.80

296

Anaemia in chronic diseases classified elsewhere

7.03

14.47

1.2

1.3

1.52

0.88

nmol/l

0.85

Moderate visual impairment, binocular

6.99

14.45

1.3

1.5

0.78

0.93

nmol/l

0.34

Intracranial injury

216

1172

1.79

14.44

1.6

1.31

1.22

nmol/l

0.49

159

930

Gout, idiopatic and unspecified

106

463

2.30

14.42

1.2

1.3

1.72

1.11

nmol/l

5.18

351

Other disorders of urethra and urinary system

253

1102

1.72

14.37

1.7

1.6

1.33

1.24

nmol/l

0.51

188

873

Benzodiazepine use

384

1762

1.55

14.32

1.6

1.30

1.25

nmol/l

0.42

290

1404

Direct fill therapy

246

2.83

14.31

1.8

1.5

1.18

1.20

nmol/l

0.04

189

Injuries to the head

414

1763

1.53

14.28

1.6

1.22

1.26

nmol/l

0.28

310

1408

Intestinal infectious diseases

352

1740

1.58

14.24

1.6

1.23

1.26

nmol/l

0.18

256

1397

Gout

122

515

2.17

14.16

1.2

1.3

1.65

1.13

nmol/l

4.68

401

Persons encountering health services for other counselling and medical advice, not elsewhere classified

424

1585

1.53

14.07

1.7

1.6

1.31

1.25

nmol/l

0.53

337

1241

Poisoning by drugs, medicaments and biological substances

103

450

2.30

14.01

1.5

1.8

1.10

1.32

nmol/l

1.26

359

Malaise and fatigue

182

810

1.88

13.99

1.6

1.5

1.33

1.21

nmol/l

0.61

134

639

Diseases of the digestive system

175

930

1.88

13.98

1.5

1.14

1.20

nmol/l

0.37

138

718

Gout, FINNGEN

122

573

2.14

13.91

1.2

1.3

1.65

1.09

nmol/l

5.29

447

Persons encountering health services in other circumstances

148

746

1.99

13.90

1.7

1.26

1.22

nmol/l

0.17

125

585

Genitourinary diseases

256

738

1.74

13.86

1.6

1.18

1.20

nmol/l

0.11

199

583

Symptoms and signs involving cognition, perception, emotional state and behaviour

366

1648

1.56

13.86

1.5

1.6

1.15

1.28

nmol/l

1.22

277

1305

Intestinal malabsorption

4.43

13.82

1.5

0.78

1.33

nmol/l

3.12

Diseases of the skin and subcutaneous tissue

400

1298

1.55

13.70

1.6

1.16

1.25

nmol/l

0.84

310

1044

Symptoms and signs involving the urinary system

291

1378

1.64

13.69

1.4

1.5

1.26

1.22

nmol/l

0.20

215

1082

Oral corticosteroids

412

1643

1.52

13.53

1.6

1.28

1.24

nmol/l

0.29

320

1300

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

111

508

2.19

13.51

1.4

1.9

1.18

1.26

nmol/l

0.34

416

Asthma

298

970

1.65

13.51

1.6

1.7

1.18

1.21

nmol/l

0.14

241

766

Poisoning by medicine

402

2.35

13.45

1.5

1.8

1.11

1.32

nmol/l

1.02

319

Inflammatory bowel disease treatment related agents

441

1676

1.50

13.34

1.6

1.27

1.24

nmol/l

0.15

343

1327

Other diseases of intestine

201

2.96

13.32

1.4

1.3

1.24

1.18

nmol/l

0.15

161

Oesophageal varices

4.57

13.10

1.2

1.3

1.32

1.18

nmol/l

0.26

Low back pain

274

1288

1.64

13.09

1.6

1.23

1.29

nmol/l

0.39

212

1026

Diabetic retinopathy, strict definition

211

1066

1.76

13.06

1.4

0.83

1.22

nmol/l

6.53

140

851

Diabetic retinopathy, excluding more controls

275

936

1.67

13.01

1.4

0.92

1.31

nmol/l

7.62

191

735

Polyarthropathies

265

1064

1.66

12.97

1.4

1.6

1.45

1.18

nmol/l

2.64

195

859

Dorsopathies

396

1324

1.53

12.93

1.6

1.7

1.13

1.29

nmol/l

2.38

306

1055

Hyperlipidaemia, other/unspecified

140

672

1.98

12.88

1.3

1.30

1.19

nmol/l

0.46

522

Personality disorders, excluding more controls

107

493

2.18

12.84

1.5

1.9

1.23

1.25

nmol/l

0.06

405

Lower back pain or/and sciatica

387

1779

1.51

12.76

1.6

1.23

1.26

nmol/l

0.25

300

1409

Hypokalaemia

169

3.10

12.75

1.5

1.3

1.31

1.15

nmol/l

0.47

133

Preparatory care for dialysis

4.34

12.69

1.9

1.4

1.36

1.13

nmol/l

0.34

Oedema, not elsewhere classified

117

558

2.09

12.67

1.3

1.5

1.32

1.20

nmol/l

0.44

434

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

213

1246

1.71

12.48

1.5

1.08

1.23

nmol/l

1.21

164

973

Pain (limb, back, neck, head abdominally)

279

849

1.65

12.45

1.7

1.5

1.26

1.27

nmol/l

0.06

213

678

Other specific joint derangements/joint disorders

280

1163

1.62

12.33

1.8

1.7

1.33

1.19

nmol/l

1.06

215

942

Visual disturbances and blindness

183

1030

1.78

12.31

1.5

1.6

1.21

nmol/l

0.03

132

806

Bacterial pneumonia, not elsewhere classified

143

655

1.94

12.28

1.4

1.5

1.36

1.19

nmol/l

0.86

125

501

Myalgia

375

2.33

12.27

2.0

1.7

1.15

1.32

nmol/l

0.87

291

Injuries to the knee and lower leg

440

1717

1.47

12.20

1.5

1.6

1.24

1.26

nmol/l

0.17

336

1365

Hyperkalaemia

4.51

12.14

1.3

1.22

0.94

nmol/l

0.77

Fever of other and unknown origin

198

1058

1.74

12.12

1.6

1.29

1.23

nmol/l

0.36

150

843

Impingement syndrome of shoulder

106

500

2.13

12.03

1.4

1.36

1.27

nmol/l

0.30

381

Extracorporeal dialysis

101

3.71

11.95

2.0

1.4

1.33

1.14

nmol/l

0.33

Kidney transplant status

4.03

11.94

2.5

1.4

1.22

1.28

nmol/l

0.08

Bleeding

307

1433

1.56

11.87

1.5

1.16

1.25

nmol/l

0.75

234

1112

All influenza

457

2.18

11.87

1.5

1.33

1.15

nmol/l

0.85

354

Bacterial pneumoniae

148

695

1.89

11.83

1.4

1.5

1.35

1.21

nmol/l

0.72

128

536

Rotator cuff syndrome

230

1027

1.67

11.65

1.5

1.4

1.25

nmol/l

0.04

185

812

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

233

1318

1.64

11.55

1.3

1.4

1.31

1.21

nmol/l

0.68

180

1023

Causalgia

6.83

11.52

1.3

1.7

1.20

1.10

nmol/l

0.11

423

1525

1.47

11.49

1.6

1.30

1.25

nmol/l

0.38

325

1202

Sciatica+with lumbago

186

1019

1.74

11.42

1.6

1.31

1.27

nmol/l

0.22

145

806

Major coronary heart disease event

264

1101

1.60

11.26

1.3

1.4

1.27

1.19

nmol/l

0.52

206

841

Dental caries 3 and operation codes

325

1082

1.54

11.18

1.5

1.6

1.31

1.21

nmol/l

0.72

252

836

Redundant prepuce, phimosis and paraphimosis

467

2.12

11.14

1.4

1.5

1.06

1.15

nmol/l

0.54

369

Alcoholic liver disease

178

2.89

11.11

1.3

1.14

1.09

nmol/l

0.14

134

Other external causes of accidental injury

319

1037

1.54

10.92

1.6

1.7

1.27

nmol/l

0.01

240

860

Impotence

3.62

10.92

1.4

1.2

1.10

1.25

nmol/l

0.34

Cough

140

723

1.86

10.89

1.6

1.5

1.60

1.18

nmol/l

2.76

102

561

Visual impairment including blindness (binocular or monocular)

104

3.50

10.71

1.2

1.3

1.11

1.10

nmol/l

0.02

Disorders of adult personality and behaviour

115

585

1.97

10.69

1.5

1.9

1.23

1.26

nmol/l

0.13

464

Pain, not elsewhere classified

102

497

2.06

10.68

1.7

1.35

1.24

nmol/l

0.39

397

Extreme obesity with alveolar hypoventilation

4.18

10.64

1.1

1.4

2.11

1.16

nmol/l

2.79

Heart failure and coronary heart disease

117

440

1.99

10.55

1.3

1.2

1.48

1.21

nmol/l

1.20

330

Asthma (mode)

281

986

1.57

10.54

1.7

1.6

1.19

1.21

nmol/l

0.13

230

779

Alcohol use disorder, ICD-based

169

976

1.74

10.50

1.5

1.04

1.28

nmol/l

2.29

127

766

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

301

2.37

10.47

1.5

1.8

1.12

1.34

nmol/l

0.93

242

Somatoform disorder

295

2.39

10.47

1.7

1.19

1.31

nmol/l

0.43

229

Gout, strict definition

314

2.34

10.43

1.1

1.2

1.85

1.08

nmol/l

5.25

239

Exclusions for E4_PCOS_BROAD

302

2.36

10.39

1.6

1.77

1.29

nmol/l

1.69

234

377

2.15

10.38

1.4

1.3

0.95

1.25

nmol/l

2.23

286

Cerebrovascular diseases

262

1201

1.57

10.32

1.4

1.15

1.24

nmol/l

0.69

200

929

Viral infections characterized by skin and mucous membrane lesions

157

892

1.76

10.30

1.7

1.6

1.28

1.22

nmol/l

0.27

118

710

Suicide or other Intentional self-harm

484

2.05

10.30

1.4

1.7

1.15

1.27

nmol/l

0.51

384

Heart failure and bmi 25plus

148

560

1.83

10.23

1.4

1.3

1.48

1.30

nmol/l

0.72

100

416

Pregnancy hypertension

138

679

1.84

10.20

2.3

1.9

1.55

1.30

nmol/l

1.41

109

550

Other abnormal uterine and vaginal bleeding

234

2.32

10.02

1.8

1.6

1.27

1.13

nmol/l

0.48

184

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

111

571

1.95

10.02

1.4

1.9

1.18

1.31

nmol/l

0.58

460

Other sleep disorders

161

2.88

9.99

1.3

1.4

1.06

1.13

nmol/l

0.18

130

Disorders of synovium and tendon

184

989

1.68

9.99

1.7

1.6

1.35

1.28

nmol/l

0.36

142

782

Ascites

114

3.28

9.99

1.2

1.4

1.32

1.20

nmol/l

0.29

Gastroduodenal ulcer

455

2.07

9.98

1.5

1.3

1.23

1.20

nmol/l

0.09

355

Other joint disorders

333

1190

1.49

9.97

1.8

1.7

1.33

1.20

nmol/l

1.27

262

960

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

149

733

1.78

9.95

2.2

1.8

1.57

1.31

nmol/l

1.64

118

593

Arthropathies in other diseases classified elsewhere

4.19

9.92

1.8

1.2

0.89

1.23

nmol/l

0.83

Irregular menses

148

672

1.79

9.91

1.9

1.44

1.32

nmol/l

0.53

120

551

Pain associated with micturition

190

2.70

9.87

1.5

1.4

1.05

1.20

nmol/l

0.53

147

Agoraphobia

5.19

9.85

1.3

1.9

1.14

1.31

nmol/l

0.18

Pre-eclampsia or eclampsia

348

2.22

9.81

1.8

1.40

1.26

nmol/l

0.44

285

Personality disorders

107

548

1.96

9.80

1.5

1.9

1.23

1.26

nmol/l

0.10

433

275

2.35

9.77

1.4

1.2

0.98

1.19

nmol/l

0.96

201

Other diseases of urinary system

364

1408

1.46

9.77

1.6

1.35

1.26

nmol/l

0.72

275

1115

Osteomyelitis

3.47

9.74

1.5

1.4

1.13

1.20

nmol/l

0.15

Bacterial pneumonia (organism specified)

157

824

1.74

9.72

1.4

1.5

1.32

1.21

nmol/l

0.55

135

625

Spondylopathies

288

1152

1.52

9.69

1.4

1.5

1.15

1.27

nmol/l

0.99

215

910

Degeneration of macula and posterior pole

146

677

1.78

9.67

1.4

1.3

0.95

1.27

nmol/l

3.77

532

Irritable bowel syndrome

489

2.01

9.66

1.8

1.7

1.32

1.24

nmol/l

0.31

392

Pre-eclampsia

319

2.27

9.63

1.9

1.8

1.48

1.31

nmol/l

0.58

260

Hypothyroidism, other/unspecified

316

1408

1.48

9.61

1.7

1.6

1.14

1.28

nmol/l

1.53

240

1113

Cervical disc disorders

138

773

1.79

9.57

1.4

1.5

1.14

1.28

nmol/l

0.86

106

604

Dental operations

238

766

1.60

9.56

1.4

1.5

1.22

nmol/l

0.02

180

593

Accidents

311

1037

1.50

9.56

1.6

1.7

1.29

1.27

nmol/l

0.07

232

860

Coronary revascularization (ANGIO or CABG)

169

691

1.71

9.42

1.3

1.27

1.18

nmol/l

0.37

126

526

Phobic anxiety disorders

218

2.53

9.41

1.4

2.0

1.33

1.36

nmol/l

0.06

181

Constipation

304

1469

1.48

9.41

1.4

1.5

1.24

1.27

nmol/l

0.12

234

1141

Asthma, hospital admission 2, infections

203

1247

1.60

9.37

1.6

1.27

1.23

nmol/l

0.19

162

967

Asthma-related infections

203

1247

1.60

9.37

1.6

1.27

1.23

nmol/l

0.19

162

967

Chronic lower respiratory diseases

439

1701

1.40

9.36

1.6

1.24

1.25

nmol/l

0.09

348

1344

Viral pneumonia

219

2.53

9.34

1.5

1.4

1.23

1.15

nmol/l

0.21

169

Mental and behavioural disorders due to alcohol, excluding acute intoxication

177

1071

1.66

9.27

1.5

1.06

1.26

nmol/l

1.78

132

843

Dental caries 1 and operation codes

306

1050

1.50

9.26

1.5

1.28

1.21

nmol/l

0.45

237

811

Specific personality disorders

443

2.04

9.24

1.5

1.9

1.28

1.29

nmol/l

0.01

352

Other diseases of the digestive system

114

609

1.88

9.23

1.5

1.4

1.24

1.16

nmol/l

0.30

458

Problems related to lifestyle

180

2.68

9.20

1.4

1.7

1.24

1.25

nmol/l

0.03

136

Anxiety (asthma-related co-morbidities)

207

1022

1.60

9.14

1.6

1.7

1.33

1.24

nmol/l

0.49

148

835

Otitis externa

412

2.07

9.11

1.8

1.5

1.24

1.23

nmol/l

0.05

318

Diabetic nephropathy

168

1000

1.68

9.07

1.6

1.4

1.08

1.18

nmol/l

0.56

126

768

Examination and observation for other reasons

160

563

1.73

9.07

1.7

1.6

1.27

1.23

nmol/l

0.17

116

475

Dizziness and giddiness

257

1377

1.52

9.05

1.6

1.5

1.17

1.27

nmol/l

0.69

199

1082

Hypothyreosis and Thyroxine purchase for inclusion criteria

319

1443

1.46

9.02

1.7

1.6

1.14

1.28

nmol/l

1.39

243

1140

Bronchitis

377

1750

1.41

8.95

1.7

1.6

1.29

1.25

nmol/l

0.29

294

1379

Other disorders of penis

177

2.68

8.95

1.4

0.95

1.16

nmol/l

0.95

136

Acute upper respiratory infections

369

1632

1.42

8.83

1.6

1.28

1.25

nmol/l

0.20

288

1285

Parodontitis or/and operation codes

252

981

1.53

8.74

1.5

1.6

1.31

1.22

nmol/l

0.64

199

782

Other arthrosis

199

891

1.60

8.69

1.4

1.21

1.16

nmol/l

0.29

157

712

Lateral epicondylitis

227

2.44

8.68

1.5

1.4

1.04

1.32

nmol/l

1.52

171

Other respiratory disorders and diseases

354

2.13

8.64

1.2

1.3

1.36

1.17

nmol/l

0.67

269

Other diseases of the respiratory system

354

2.13

8.64

1.2

1.3

1.36

1.17

nmol/l

0.67

269

Open wound of ankle and foot

198

2.54

8.62

2.1

1.6

1.07

1.24

nmol/l

0.46

155

Opening and dilatation of root channel of tooth

125

2.99

8.62

2.2

1.5

1.61

1.28

nmol/l

0.81

102

Non-selective monoamine reuptake inhibitors

134

745

1.75

8.60

1.5

1.4

1.27

1.19

nmol/l

0.31

100

602

Gingivitis and periodontal diseases

324

1151

1.46

8.58

1.6

1.25

1.24

nmol/l

0.02

247

927

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

164

2.70

8.56

1.5

1.4

1.37

1.20

nmol/l

0.49

128

Diseases of the respiratory system

239

772

1.55

8.56

1.6

1.7

1.33

1.21

nmol/l

0.82

191

614

Adhesive capsulitis of shoulder

291

2.24

8.54

1.5

1.4

1.14

1.26

nmol/l

0.38

220

153

907

1.68

8.47

1.6

1.7

1.33

1.23

nmol/l

0.48

122

709

Dental pulpitis 2, only avohilmo

246

820

1.54

8.47

1.4

1.5

1.28

1.20

nmol/l

0.42

190

636

Early onset COPD, excluding more controls

398

2.04

8.39

1.4

1.27

1.18

nmol/l

0.29

300

Injuries to the wrist and hand

348

1789

1.41

8.35

1.6

1.20

1.26

nmol/l

0.51

268

1421

External causes of morbidity and mortality

242

789

1.54

8.33

1.6

1.7

1.21

1.34

nmol/l

0.90

184

654

Spinal stenosis

176

851

1.62

8.31

1.3

1.4

1.09

1.29

nmol/l

1.68

130

656

Acute sinusitis

187

1099

1.59

8.30

1.7

1.30

1.21

nmol/l

0.48

146

877

Mental and behavioural disorders due to alcohol

194

1204

1.57

8.26

1.5

1.04

1.26

nmol/l

2.17

145

954

Barrett oesophagus

3.55

8.26

1.3

1.4

1.61

1.13

nmol/l

0.59

Other diseases of biliary tract

123

2.95

8.22

1.3

1.15

1.20

nmol/l

0.10

Acute bronchitis

141

815

1.70

8.20

1.6

1.34

1.22

nmol/l

0.52

105

640

Gastric ulcer

291

2.21

8.12

1.6

1.3

1.28

1.14

nmol/l

0.44

228

Visual disturbances

156

949

1.65

8.11

1.6

1.22

1.21

nmol/l

0.05

112

748

Conductive and sensorineural hearing loss

274

1294

1.47

8.08

1.4

1.10

1.25

nmol/l

1.72

211

1004

Coronary angioplasty

135

601

1.73

8.04

1.3

1.32

1.19

nmol/l

0.52

103

449

Syncope and collapse

151

805

1.67

8.04

1.3

1.5

1.46

1.22

nmol/l

1.40

116

630

Rheumatism, unspecified

211

2.43

8.04

1.6

1.4

1.08

1.29

nmol/l

0.89

163

Schizophrenia or delusion, excluding more controls

107

583

1.83

8.00

1.5

1.8

1.38

1.23

nmol/l

0.63

475

Finngen Rheumatological endpoints

360

1466

1.40

7.98

1.7

1.6

1.29

1.22

nmol/l

0.60

279

1170

Post-traumatic stress disorder

104

3.09

7.97

1.8

2.3

1.32

1.48

nmol/l

0.27

Exclusions for E4_PCOS_CONSORTIUM

231

953

1.52

7.95

1.6

1.8

1.28

1.29

nmol/l

0.01

176

768

Pre-eclampsia or poor fetal growth

510

1.88

7.91

2.0

2.1

1.36

1.34

nmol/l

0.06

425

Bipolar affective disorders

328

2.11

7.84

1.4

1.8

1.19

1.27

nmol/l

0.22

257

Hyperkinetic disorders, excluding more controls

3.12

7.80

2.3

2.7

1.27

1.30

nmol/l

0.05

Other symptoms and signs involving cognitive functions and awareness

148

840

1.66

7.80

1.4

1.11

1.21

nmol/l

0.56

112

653

Dental pulpitis 2

236

796

1.52

7.77

1.4

1.5

1.28

1.21

nmol/l

0.43

180

618

Asthma-related pneumonia

118

673

1.76

7.76

1.4

1.5

1.26

1.25

nmol/l

0.03

510

Disorders of skin appendages

166

1037

1.60

7.76

1.7

1.18

1.22

nmol/l

0.20

126

827

Dental caries 3

278

969

1.47

7.75

1.5

1.28

1.20

nmol/l

0.52

217

751

Sequelae of external causes of morbidity and mortality

480

1.90

7.75

1.5

1.4

1.07

1.21

nmol/l

0.75

367

Ischaemic Stroke, excluding all haemorrhages

189

912

1.57

7.74

1.3

1.18

1.23

nmol/l

0.28

147

700

Dental caries, including avohilmo

267

924

1.48

7.72

1.4

1.5

1.28

1.21

nmol/l

0.48

206

716

Asthma, hospital admissions 3, pneumonia

118

674

1.75

7.72

1.4

1.5

1.26

1.25

nmol/l

0.03

511

Asthma-related pneumonia or sepsis

118

674

1.75

7.72

1.4

1.5

1.26

1.25

nmol/l

0.03

511

Arthrosis

271

1015

1.47

7.72

1.6

1.5

1.23

1.17

nmol/l

0.54

204

818

Other and unspecified mononeuropathies, also in other diseases

4.37

7.70

1.5

1.39

1.14

nmol/l

0.31

Exposure to other specified factors

257

1655

1.46

7.69

1.6

1.25

nmol/l

0.01

192

1319

Emergency coronary revascularization (for ACS)

191

878

1.57

7.68

1.3

1.31

1.20

nmol/l

0.56

146

663

Other gastritis (incl. Duodenitis)

412

1.97

7.67

1.3

1.24

1.22

nmol/l

0.04

322

Sequelae of injuries, of poisoning and of other consequences of external causes

489

1.89

7.66

1.9

1.5

1.07

1.24

nmol/l

0.88

375

Unspecified mental disorder

151

926

1.63

7.63

1.5

1.8

1.43

1.19

nmol/l

1.57

114

740

Use of hypnotics and sedatives

384

1618

1.37

7.61

1.5

1.6

1.27

1.22

nmol/l

0.29

292

1286

Deposits [accretions] on teeth

108

2.97

7.61

1.6

1.31

1.16

nmol/l

0.29

Certain disorders involving the immune mechanism

366

2.03

7.59

1.2

1.4

1.19

1.23

nmol/l

0.11

283

Other headache syndromes

131

776

1.69

7.57

2.0

1.6

1.23

1.18

nmol/l

0.24

629

All anxiety disorders

210

1113

1.52

7.57

1.6

1.8

1.32

1.25

nmol/l

0.37

150

902

Covid-19 confirmed case

100

548

1.83

7.56

1.5

1.6

1.20

1.26

nmol/l

0.22

427

Striking against or struck by other objects

121

702

1.73

7.53

1.6

1.17

1.23

nmol/l

0.22

559

Other disorders of lacrimal gland

114

651

1.76

7.52

1.6

1.31

1.24

nmol/l

0.25

509

Hypothyroidism, strict autoimmune, 3 medication purchases required

279

1321

1.44

7.52

1.7

1.6

1.20

1.27

nmol/l

0.45

215

1037

Diagnoses used for exclusion with ILD

485

1.88

7.52

1.2

1.3

1.12

1.22

nmol/l

0.35

367

GI-bleeding

109

615

1.78

7.49

1.4

1.3

1.26

1.14

nmol/l

0.55

467

Sequelae with surgical and medical care as external cause

362

2.03

7.44

1.5

1.4

1.11

1.22

nmol/l

0.49

275

Flat foot [pes planus] (acquired)

159

2.60

7.43

1.4

1.2

1.24

1.16

nmol/l

0.19

117

Disorders of eyelid, lacrimal system and orbit

283

1556

1.43

7.42

1.5

1.6

1.19

1.27

nmol/l

0.62

216

1220

Paralytic ileus and intestinal obstruction

452

1.91

7.41

1.3

1.22

1.20

nmol/l

0.07

350

Dental caries 1

266

928

1.47

7.41

1.4

1.5

1.28

1.20

nmol/l

0.51

205

719

Maternal care for other conditions predominantly related to pregnancy

266

2.20

7.41

1.9

2.1

1.15

1.36

nmol/l

0.91

221

Other acute lower respiratory infections

181

1113

1.56

7.39

1.6

1.31

1.23

nmol/l

0.38

135

879

Other diseases of jaws

120

2.86

7.37

2.1

1.3

1.37

1.06

nmol/l

0.87

Disorders of the thyroid gland

327

1531

1.40

7.36

1.7

1.6

1.12

1.29

nmol/l

2.05

250

1203

Arthropathies

329

1191

1.41

7.35

1.9

1.7

1.36

1.20

nmol/l

1.52

255

960

Diseases of oral cavity, salivary glands and jaws

318

1154

1.42

7.34

1.6

1.25

1.24

nmol/l

0.02

239

929

Asthma (only as main-diagnosis), excluding more controls

229

913

1.50

7.26

1.6

1.7

1.29

1.19

nmol/l

0.60

183

732

Epilepsy

100

554

1.80

7.25

1.5

1.6

1.19

1.17

nmol/l

0.09

445

Stroke, including SAH

213

1050

1.50

7.20

1.4

1.3

1.17

1.24

nmol/l

0.44

166

806

Disorders of vitreous body

160

990

1.59

7.15

1.7

1.4

1.05

1.23

nmol/l

1.37

113

766

Ingrowing nail

3.14

7.14

2.0

1.4

0.92

1.23

nmol/l

0.71

Other disorders of ear

316

1509

1.40

7.13

1.6

1.5

1.17

1.26

nmol/l

0.79

251

1185

Diseases of external ear

116

677

1.72

7.11

1.7

1.5

1.30

1.22

nmol/l

0.27

527

Ventral hernia

474

1.86

7.07

1.4

1.3

1.30

1.23

nmol/l

0.22

368

Mycoses

517

1.82

7.06

1.5

1.37

1.25

nmol/l

0.46

402

Sensorineural hearing loss

255

1236

1.45

7.04

1.4

1.09

1.25

nmol/l

1.77

198

954

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

335

1582

1.38

7.03

1.5

1.30

1.24

nmol/l

0.43

250

1253

Non-ischemic cardiomyopathy

421

1.84

7.01

1.4

1.3

1.43

1.23

nmol/l

0.72

322

Internal derangement of knee

137

837

1.64

7.00

1.6

1.22

1.14

nmol/l

0.32

671

Injuries to the ankle and foot

234

1465

1.46

7.00

1.7

1.17

1.26

nmol/l

0.59

184

1166

Decubitus ulcer and pressure area

3.17

6.99

1.2

1.3

1.34

1.08

nmol/l

0.48

Acute upper respiratory infections of multiple and unspecified sites

251

1303

1.45

6.99

1.8

1.7

1.29

1.24

nmol/l

0.30

200

1029

Other diseases of anus and rectum

540

1.80

6.98

1.8

1.4

1.36

1.23

nmol/l

0.52

418

Dermatitis and eczema

374

1813

1.35

6.96

1.7

1.6

1.29

1.25

nmol/l

0.25

292

1432

Dental operations, only avohilmo

241

838

1.48

6.94

1.4

1.5

1.25

1.22

nmol/l

0.16

186

642

Disorders of vitreous body and globe

163

1017

1.57

6.93

1.7

1.4

1.05

1.23

nmol/l

1.34

115

788

Fracture of lower leg, including ankle

187

1229

1.52

6.93

1.5

1.6

1.06

1.22

nmol/l

1.40

142

965

Other and unspecified disorders of skin and subcutaneous tissue

119

2.80

6.90

1.3

1.4

1.26

1.24

nmol/l

0.03

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

162

802

1.58

6.89

1.3

1.4

1.02

1.25

nmol/l

2.65

130

606

ILD medications: immunosuppressive drugs

208

1346

1.48

6.89

1.6

1.30

1.24

nmol/l

0.27

161

1077

Stroke, excluding SAH

200

987

1.51

6.88

1.3

1.18

1.23

nmol/l

0.28

155

762

Benign neoplasms

354

1446

1.37

6.85

1.5

1.7

1.18

1.28

nmol/l

0.82

274

1151

KRA_PSY_EATING, excluding more controls

3.05

6.84

2.3

2.7

1.41

1.49

nmol/l

0.13

Abnormal findings on diagnostic imaging of lung

161

1005

1.56

6.80

1.3

1.31

1.20

nmol/l

0.54

124

772

Chronic periodontitis

274

2.13

6.77

1.4

1.3

1.38

1.14

nmol/l

0.93

215

Osteopathies and chondropathies

180

1123

1.52

6.74

1.5

1.17

1.21

nmol/l

0.23

140

868

Diabetic retinopathy

324

1489

1.38

6.73

1.4

0.91

1.28

nmol/l

8.66

224

1180

Kela-code for severe mental illness

134

827

1.62

6.67

1.5

1.7

1.43

1.20

nmol/l

1.47

105

653

Dermatitis

202

1366

1.48

6.67

1.6

1.5

1.26

1.25

nmol/l

0.03

161

1072

Diseases of the musculoskeletal system and connective tissue

192

629

1.53

6.63

1.6

1.7

1.38

1.25

nmol/l

0.69

154

513

Sequelae of injuries of head

3.06

6.62

1.6

1.5

0.78

1.33

nmol/l

3.05

Other neurological diseases

236

1317

1.44

6.61

1.4

1.5

1.23

1.24

nmol/l

0.04

184

1025

Transport accidents

152

856

1.58

6.60

1.7

1.19

1.25

nmol/l

0.23

120

715

Other enthesopathies

100

574

1.75

6.54

1.4

1.5

1.11

1.25

nmol/l

0.77

443

Amputation of foot

4.39

6.51

1.4

1.1

1.24

0.89

nmol/l

—

Ulcer of oesophagus

101

2.89

6.47

1.2

1.3

1.64

1.16

nmol/l

0.72

Benign neoplasm of other and unspecified endocrine glands

227

2.21

6.46

1.4

1.41

1.19

nmol/l

0.72

176

Other and unspecified nonorganic psychotic disorders

354

1.96

6.45

1.6

1.8

1.42

1.27

nmol/l

0.50

278

Behavioural syndromes associated with physiological disturbances and physical factors

104

606

1.72

6.44

1.7

1.9

1.31

1.30

nmol/l

0.03

475

Postpartum care and examination

143

2.28

6.44

2.3

2.0

1.18

1.48

nmol/l

1.09

118

Disorders of mineral metabolism

118

2.73

6.43

1.7

1.3

1.37

1.16

nmol/l

0.47

Injury, poisoning and certain other consequences of external causes

191

629

1.52

6.42

1.6

1.8

1.31

1.34

nmol/l

0.12

149

520

Unspecified jaundice

3.23

6.42

1.2

1.3

1.05

1.15

nmol/l

0.20

Suppurative and unspecified otitis media

116

615

1.68

6.42

1.9

1.44

1.23

nmol/l

0.92

488

Asthma (only as main-diagnosis)

233

970

1.45

6.42

1.6

1.7

1.29

1.21

nmol/l

0.53

187

766

Volume depletion

124

2.68

6.40

1.5

1.3

1.15

1.01

nmol/l

0.22

Benign neoplasm: Colon, unspecified

455

1.83

6.35

1.6

1.3

1.18

1.19

nmol/l

0.03

347

Ovarian dysfunction: androgen excess

+∞

6.35

2.5

0.0

2.30

—

nmol/l

—

L04AA Selective immunosuppressants

427

1.86

6.33

1.8

1.5

1.37

1.23

nmol/l

0.37

333

Superficial injury of wrist and hand

364

1.93

6.30

1.8

1.7

1.17

1.26

nmol/l

0.33

286

Other eating disorders

3.47

6.29

2.0

2.8

1.33

1.43

nmol/l

0.13

Unstable angina pectoris

130

666

1.62

6.28

1.2

1.3

1.28

1.18

nmol/l

0.54

103

498

Inflammatory diseases of female pelvic organs

174

865

1.52

6.25

1.8

1.45

1.30

nmol/l

0.95

130

709

Autoimmune diseases related-to ILD

286

1831

1.38

6.21

1.6

1.32

1.23

nmol/l

0.69

223

1446

Superficial injury of lower leg

444

1.83

6.21

1.9

1.7

1.32

1.25

nmol/l

0.25

351

Other or unspecified ileus, impaction or obstruction

311

2.00

6.19

1.3

1.12

1.17

nmol/l

0.14

240

Symptoms and signs concerning food and fluid intake

156

2.45

6.16

1.8

1.4

0.93

1.16

nmol/l

1.13

117

Cystitis

265

1156

1.40

6.12

1.8

1.6

1.29

1.26

nmol/l

0.16

204

917

Missing teeth due to accident, extraction or parodontitis

194

2.28

6.11

1.7

1.3

1.23

1.18

nmol/l

0.11

150

Convulsions, not elsewhere classified

427

1.83

6.08

1.7

1.6

1.34

1.21

nmol/l

0.42

336

Hernia of abdominal wall

156

1022

1.53

6.06

1.5

1.29

1.22

nmol/l

0.26

119

798

Transient ischemic attack

166

908

1.52

6.06

1.3

1.18

1.23

nmol/l

0.20

129

702

Disorders of lacrimal system

132

833

1.59

6.05

1.6

1.27

1.23

nmol/l

0.15

651

Dental caries 3, only avohilmo

277

1015

1.40

6.04

1.5

1.27

1.22

nmol/l

0.34

217

788

Candidiasis

234

2.15

6.02

1.6

1.5

1.53

1.23

nmol/l

0.90

181

Hepatic failure, not elsewhere classified

3.37

6.01

1.4

1.30

1.06

nmol/l

0.51

Open wound of lower leg

248

2.11

5.97

1.5

1.15

1.18

nmol/l

0.08

192

Papulosquamous disorders

134

852

1.58

5.95

1.6

1.5

1.43

1.19

nmol/l

1.35

108

664

Alcohol abuse, main dg, excluding more controls

275

2.04

5.95

1.3

1.6

1.07

1.18

nmol/l

0.36

217

Emotionally unstable personality disorder

203

2.23

5.93

1.5

2.0

1.11

1.39

nmol/l

0.84

172

Diseases of middle ear and mastoid

189

1055

1.47

5.90

1.8

1.43

1.21

nmol/l

1.46

145

846

Neuromuscular dysfunction of bladder

160

2.39

5.87

1.7

1.4

1.37

1.13

nmol/l

0.42

126

Viral and other specified intestinal infections

358

1.89

5.83

1.8

2.0

1.21

1.29

nmol/l

0.21

296

Exposure to unspecified factor

321

1862

1.34

5.80

1.6

1.22

1.26

nmol/l

0.20

235

1486

Smoking dependency

161

2.38

5.80

1.4

1.35

1.25

nmol/l

0.21

127

Mental and behavioural disorders due to tobacco

161

2.38

5.80

1.4

1.35

1.24

nmol/l

0.22

126

Other female pelvic inflammatory diseases

278

2.02

5.79

1.7

1.24

1.31

nmol/l

0.17

223

Benign neoplasms

282

1160

1.38

5.78

1.5

1.8

1.16

1.30

nmol/l

1.35

218

933

COPD-related respiratory insufficiency

199

2.22

5.78

1.3

1.54

1.13

nmol/l

1.61

149

Sequelae of cerebrovascular disease

108

574

1.66

5.75

1.3

1.05

1.19

nmol/l

0.76

437

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

177

1179

1.47

5.73

1.5

1.36

1.23

nmol/l

0.73

139

931

Benign neoplasm of other and unspecified endocrine glands

239

2.10

5.72

1.4

1.41

1.30

nmol/l

0.29

182

Malignant neoplasm of digestive organs

119

731

1.61

5.72

1.3

1.03

1.18

nmol/l

1.14

550

Asthma (diagnoses ohter than nonallergic)

281

1770

1.36

5.69

1.6

1.25

1.26

nmol/l

0.06

227

1385

Sarcoidosis

253

2.07

5.68

1.3

1.4

1.16

1.20

nmol/l

0.07

195

Benign neoplasm of colon, rectum, anus and anal canal

197

1237

1.44

5.63

1.4

1.3

1.18

1.24

nmol/l

0.33

148

955

Cholecystitis

222

2.13

5.55

1.4

1.3

1.19

1.26

nmol/l

0.18

170

Myocardial infarction, unclassifiable

332

1.86

5.51

1.3

1.31

1.23

nmol/l

0.20

248

Other reaction to severe stress, and adjustment disorders

119

751

1.59

5.49

1.7

1.8

1.12

1.24

nmol/l

0.59

609

Supplementary factors related to causes of morbidity and mortality classified elsewhere

102

620

1.65

5.49

1.5

1.6

1.19

1.24

nmol/l

0.19

480

Benign neoplasm: Colon

166

1103

1.48

5.48

1.5

1.3

1.17

1.22

nmol/l

0.24

124

847

Dental caries 1, only avohilmo

263

973

1.38

5.47

1.4

1.5

1.27

1.22

nmol/l

0.30

204

755

Benign neoplasm: Colon, unspecified

476

1.74

5.43

1.6

1.4

1.18

1.22

nmol/l

0.16

354

Open wound of head

170

1144

1.47

5.42

1.5

1.19

1.23

nmol/l

0.18

122

898

Follow-up examination after treatment for malignant neoplasms

100

2.71

5.42

2.0

1.3

1.19

1.27

nmol/l

0.15

Other bacterial intestinal infections

306

1.93

5.41

1.5

1.3

1.28

1.24

nmol/l

0.08

236

Haemorrhage from respiratory passages

105

597

1.64

5.41

1.3

1.4

1.34

1.18

nmol/l

0.80

450

Mental retardation, excluding more controls

3.77

5.39

1.3

1.8

1.64

1.25

nmol/l

0.25

Other symptoms and signs involving the digestive system and abdomen

252

2.03

5.36

1.7

1.5

1.13

1.24

nmol/l

0.29

201

Assault

253

2.02

5.32

1.5

1.7

1.03

1.30

nmol/l

0.95

199

Nail disorders

149

2.36

5.31

1.8

1.4

0.92

1.20

nmol/l

0.87

121

Other diseases of hard tissues of teeth

205

1078

1.42

5.31

1.7

1.6

1.20

1.23

nmol/l

0.18

158

873

Preterm labour and delivery

430

1.77

5.31

1.4

1.8

1.18

1.36

nmol/l

0.96

349

Intestinal stricture

595

1.65

5.31

1.3

1.19

1.21

nmol/l

0.05

459

Injuries to the shoulder and upper arm

274

1705

1.35

5.31

1.4

1.5

1.19

1.24

nmol/l

0.33

217

1335

Focal brain injury

2.93

5.30

1.3

1.39

1.10

nmol/l

0.59

Benign neoplasm: Colon

165

859

1.47

5.24

1.5

1.4

1.17

1.26

nmol/l

0.51

124

658

Coronary artery bypass grafting

415

1.69

5.23

1.2

1.3

1.24

1.18

nmol/l

0.19

312

Diseases of the myoneural junction and muscle

221

2.09

5.23

1.3

1.4

1.84

1.18

nmol/l

1.94

171

Other specified and unspecified personality disorders

169

2.26

5.22

1.3

1.6

1.25

1.29

nmol/l

0.09

137

Psoriasis vulgaris

367

1.83

5.22

1.7

1.4

1.45

1.23

nmol/l

0.75

281

Other CVD

310

1.91

5.22

1.3

0.98

1.17

nmol/l

0.74

240

Enterocolitis due to Clostridium difficile

169

2.26

5.22

1.6

1.3

1.49

1.15

nmol/l

0.62

130

Persistent mood disorders

360

1.84

5.21

1.4

1.5

1.49

1.22

nmol/l

0.92

276

Eating disorder

108

2.60

5.20

2.3

2.4

1.41

1.49

nmol/l

0.13

Benign neoplasm of colon, rectum, anus and anal canal

186

925

1.44

5.16

1.4

1.19

1.27

nmol/l

0.55

141

716

Conduction disorders

470

1.67

5.14

1.5

1.3

1.31

1.20

nmol/l

0.31

356

Gonarthrosis

226

932

1.39

5.04

1.5

1.4

1.34

1.16

nmol/l

1.75

168

750

Temporomandibular joint disorders

231

2.04

5.04

2.1

1.5

1.00

1.22

nmol/l

0.70

183

Alcohol dependence

101

628

1.61

5.01

1.4

1.07

1.23

nmol/l

0.86

487

Herpesviral [herpes simplex] infections

205

2.11

5.00

1.4

1.16

1.25

nmol/l

0.22

164

COPD related to multimorbidity

125

684

1.54

5.00

1.3

1.42

1.17

nmol/l

1.31

519

therapeutic use

3.93

5.00

1.2

1.6

1.25

1.23

nmol/l

—

Asthma, including avohilmo

393

1785

1.28

4.98

1.6

1.27

1.25

nmol/l

0.09

310

1407

Fissure and fistula of anal and rectal regions

484

1.70

4.97

1.8

1.5

1.18

1.22

nmol/l

0.10

387

Stomatitis and related lesions

135

2.38

4.97

1.7

1.6

1.64

1.17

nmol/l

1.07

107

Chronic diseases of tonsils and adenoids

267

1256

1.35

4.94

1.9

1.6

1.22

1.24

nmol/l

0.14

216

1001

Calcific aortic valvular stenosis, diagnosis (helper)

489

1.69

4.93

1.4

1.2

1.26

1.20

nmol/l

0.20

357

Operations 2 for CAVS

489

1.69

4.93

1.4

1.2

1.26

1.20

nmol/l

0.20

357

Disorders of ocular muscles, binocular movement, accommodation and refraction

145

972

1.48

4.93

1.7

1.18

1.23

nmol/l

0.22

119

773

Acute alcohol intoxication, ICD10

404

1.76

4.91

1.3

1.6

1.06

1.21

nmol/l

0.55

317

Ulcerative colitis, NAS

261

1.96

4.90

1.6

1.5

1.12

1.27

nmol/l

0.61

199

Calcific aortic valvular stenosis

490

1.68

4.90

1.4

1.2

1.26

1.19

nmol/l

0.20

358

Calcific aortic valvular stenosis, operated

490

1.68

4.90

1.4

1.2

1.26

1.19

nmol/l

0.20

358

Chronic periodontitis, complicated

174

2.20

4.90

1.4

1.3

1.40

1.19

nmol/l

0.58

134

Fall on same level involving ice and snow

182

1287

1.42

4.89

1.5

1.6

1.14

1.23

nmol/l

0.57

133

1009

Sequelae of injuries of upper limb

194

2.12

4.87

1.6

1.4

1.15

1.24

nmol/l

0.31

151

Other and unspecified local infections of skin and subcutaneous tissue

168

2.21

4.87

1.7

1.3

1.30

nmol/l

0.00

132

Noninfective enteritis and colitis

151

1031

1.47

4.87

1.5

1.6

1.26

1.21

nmol/l

0.25

120

821

Follicular cysts of skin and subcutaneous tissue

340

1.83

4.84

1.6

1.4

1.18

1.23

nmol/l

0.15

267

Hernia

314

1630

1.31

4.82

1.5

1.24

nmol/l

0.01

240

1288

Calcific aortic valvular stenosis, including rheumatic fever

493

1.67

4.78

1.4

1.2

1.26

1.20

nmol/l

0.17

359

Other metabolic disorders

189

2.12

4.77

1.8

1.5

1.13

1.35

nmol/l

0.68

150

Car occupant injured in other and unspecified transport accidents

349

1.81

4.77

2.0

1.7

1.23

1.28

nmol/l

0.10

275

Early onset COPD

483

1.68

4.75

1.4

1.3

1.28

1.17

nmol/l

0.36

371

Plantar fascial fibromatosis

157

2.24

4.74

2.2

1.4

1.29

1.36

nmol/l

0.16

117

Other diseases of stomach and duodenum

2.62

4.73

1.3

1.4

1.02

1.22

nmol/l

0.49

Lesion of ulnar nerve

244

1.98

4.72

1.3

1.4

1.27

1.22

nmol/l

0.10

183

Type of accident

568

1.62

4.72

1.5

1.6

1.21

1.25

nmol/l

0.12

438

Urolithiasis

108

693

1.56

4.71

1.5

1.4

1.39

1.19

nmol/l

0.81

532

Schizophrenia, schizotypal and delusional disorders

109

701

1.56

4.71

1.5

1.7

1.35

1.18

nmol/l

0.80

553

Other diseases of upper respiratory tract

372

1514

1.28

4.71

1.7

1.5

1.23

1.24

nmol/l

0.03

291

1193

Burns and corrosions

266

1.93

4.66

1.8

1.6

1.04

1.22

nmol/l

0.46

206

Polyuria

418

1.73

4.66

1.8

1.3

1.26

1.21

nmol/l

0.14

318

Chronic suppurative otitis media, including avohilmo

133

2.34

4.66

1.6

1.5

1.38

1.13

nmol/l

0.61

105

Fall on and from stairs and steps

479

1.67

4.63

1.4

1.5

1.26

1.22

nmol/l

0.10

363

Non-rheumatic valve diseases

149

743

1.47

4.62

1.4

1.3

1.21

1.19

nmol/l

0.04

118

568

Calculus of kidney and ureter

102

650

1.57

4.60

1.5

1.3

1.40

1.20

nmol/l

0.76

502

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

102

650

1.57

4.60

1.6

1.7

1.33

1.22

nmol/l

0.48

505

Other local infections of skin and subcutaneous tissue

179

2.13

4.59

1.7

1.3

1.27

1.29

nmol/l

0.04

139

Viral warts

179

2.13

4.59

2.2

1.5

1.16

1.28

nmol/l

0.23

145

Psoriasis

612

1.59

4.57

1.5

1.46

1.22

nmol/l

1.08

476

Other disorders of kidney and ureter

227

1.99

4.54

1.2

1.3

1.59

1.13

nmol/l

1.12

174

Pacemaker

580

1.60

4.54

1.2

1.3

1.19

1.18

nmol/l

0.02

430

AV-block

249

1.90

4.53

1.2

1.19

1.15

nmol/l

0.06

182

Valvular heart disease excluding rheumatic fever

149

747

1.46

4.53

1.4

1.3

1.21

1.19

nmol/l

0.06

118

571

Psychotic depression

2.73

4.51

1.6

1.14

1.22

nmol/l

0.14

Injuries to the abdomen, lower back, lumbar spine and pelvis

120

791

1.51

4.51

1.3

1.5

1.21

1.25

nmol/l

0.16

615

Diaphragmatic hernia

113

741

1.53

4.50

1.5

1.3

1.33

1.21

nmol/l

0.46

571

Other and unspecified effects of external causes

506

1.64

4.49

1.5

1.8

1.14

1.25

nmol/l

0.41

398

Diseases of male genital organs

201

729

1.40

4.49

1.3

1.4

1.04

1.23

nmol/l

1.78

153

567

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

123

2.37

4.48

1.1

1.3

1.23

1.13

nmol/l

0.23

Spontaneous rupture of synovium and tendon

123

2.37

4.48

1.8

1.3

1.23

1.14

nmol/l

0.21

Other respiratory diseases principally affecting the interstitium

306

1.84

4.46

1.5

1.3

1.34

1.16

nmol/l

0.58

228

Disorders of parathyroid gland

345

1.78

4.45

1.3

1.45

1.18

nmol/l

0.93

264

215

2.01

4.45

2.3

1.6

1.15

1.25

nmol/l

0.26

166

Eating disorders

155

2.20

4.44

2.1

1.30

1.43

nmol/l

0.28

129

Nonorganic sleeping disorders, excluding more controls

292

1.85

4.44

1.5

1.8

1.30

1.29

nmol/l

0.01

232

Diseases of salivary glands

350

1.78

4.44

1.3

1.5

1.25

1.23

nmol/l

0.05

278

Fracture of foot, except ankle

462

1.67

4.44

1.6

1.7

1.20

1.30

nmol/l

0.29

359

Otitis externa, unspecified

195

2.06

4.43

1.8

1.4

1.30

1.21

nmol/l

0.17

151

Fibroblastic disorders

432

1.69

4.43

1.7

1.3

1.24

1.26

nmol/l

0.05

331

Mixed and other personality disorders

149

2.23

4.43

1.3

1.6

1.15

1.32

nmol/l

0.41

121

Artrosis, including avohilmo

299

1257

1.31

4.43

1.7

1.5

1.31

1.21

nmol/l

0.76

230

1018

Lichen simplex chronicus and prurigo

118

2.39

4.40

1.2

1.3

1.34

1.22

nmol/l

0.22

Other diseases of blood and blood-forming organs

118

2.39

4.40

1.5

1.4

1.82

1.21

nmol/l

1.20

Other and unspecified injuries of head

2.63

4.39

2.0

1.4

1.60

1.26

nmol/l

0.38

Heartburn

156

2.19

4.39

1.7

1.4

1.90

1.19

nmol/l

2.80

127

Bell's palsy

190

2.06

4.33

1.7

1.4

1.30

1.17

nmol/l

0.29

147

Other diseases of blood and blood-forming organs, wide

420

1.70

4.33

1.5

1.4

1.54

1.25

nmol/l

1.24

314

Ovarian cyst

360

1.59

4.32

2.0

1.9

1.36

1.24

nmol/l

0.48

287

Pain and other conditions associated with female genital organs and menstrual cycle

289

1.83

4.32

2.3

2.0

1.13

1.24

nmol/l

0.29

237

Fibromyalgia

119

2.36

4.31

2.1

1.4

1.58

1.37

nmol/l

0.49

Soft tissue disorders related to use, overuse and pressure

489

1.64

4.31

1.5

1.4

1.07

1.25

nmol/l

0.69

372

Bronchitis, not specified as acute or chronic

151

2.20

4.30

2.1

1.3

1.20

1.18

nmol/l

0.03

114

Neoplasms

268

1089

1.32

4.28

1.6

1.8

1.14

1.29

nmol/l

1.40

204

878

Schizophrenia or delusion

107

702

1.53

4.27

1.5

1.7

1.38

1.19

nmol/l

0.90

554

Abnormal weight loss

145

2.22

4.27

1.8

1.3

0.82

1.20

nmol/l

2.77

114

Speech disturbances, not elsewhere classified

145

2.22

4.27

1.6

1.3

1.49

1.15

nmol/l

0.63

113

Other noninfective gastroenteritis and colitis

452

1.66

4.25

1.5

1.6

1.21

1.28

nmol/l

0.20

347

Postprocedural musculoskeletal disorders, not elsewhere classified

120

2.35

4.25

1.5

1.3

1.15

1.18

nmol/l

0.07

Hypotension

261

1.88

4.24

1.4

1.3

1.08

1.14

nmol/l

0.14

197

Chronic laryngitis and laryngotracheitis

240

1.92

4.23

1.6

1.4

1.45

1.29

nmol/l

0.41

180

Other diseases of lip and oral mucosa

290

1.83

4.22

1.4

1.3

1.23

1.21

nmol/l

0.03

224

Bacterial intestinal infections, IBD co-morbidities

327

1.78

4.19

1.6

1.3

1.33

1.22

nmol/l

0.23

251

Unspecified fall

147

1023

1.43

4.19

1.5

1.6

1.14

1.23

nmol/l

0.46

113

797

Hyperkinetic disorders

138

2.22

4.17

2.3

2.5

1.27

1.37

nmol/l

0.16

118

Acute suppurative otitis media

438

1.64

4.17

2.1

2.0

1.61

1.23

nmol/l

1.60

356

Use of disulfiram, acamprosate or naltrexone

187

2.04

4.13

1.3

1.4

1.00

1.23

nmol/l

0.77

145

Subjective visual disturbances

449

1.65

4.12

1.8

1.5

1.34

1.26

nmol/l

0.21

351

Diabetic neuropathy

107

706

1.52

4.12

1.5

1.4

1.09

1.20

nmol/l

0.40

539

Other anxiety disorders

137

842

1.44

4.12

1.6

1.9

1.29

1.26

nmol/l

0.10

686

Disturbance of activity and attention

120

2.31

4.11

2.3

2.6

1.28

1.38

nmol/l

0.14

104

Sleep disorders

397

1.69

4.08

1.4

1.7

1.31

nmol/l

0.02

313

Benign neoplasm: Pancreas

3.55

4.06

1.6

1.5

0.89

1.11

nmol/l

0.63

Chronic suppurative otitis media

104

2.42

4.05

1.7

1.5

1.38

1.20

nmol/l

0.32

Hypertrophy of breast in women and men

353

1.73

4.05

1.9

1.7

1.29

nmol/l

0.01

285

Postprocedural endocrine and metabolic disorders, not elsewhere classified

175

2.06

4.04

1.9

1.5

1.10

1.35

nmol/l

0.72

137

Unspecified kidney failure

142

2.19

4.04

1.3

1.42

1.03

nmol/l

0.93

102

Traumatic subdural haemorrhage

140

2.18

4.00

1.5

1.2

1.34

1.19

nmol/l

0.31

115

Abnormalities of heart beat

611

1.54

4.00

1.8

1.6

1.29

1.17

nmol/l

0.50

473

Dysphagia

416

1.66

3.95

1.5

1.4

0.95

1.21

nmol/l

1.71

326

Diseases of peritoneum

170

2.07

3.95

2.2

1.3

1.16

1.19

nmol/l

0.05

135

Other and unspecified dermatitis

155

1111

1.40

3.95

1.7

1.6

1.20

1.23

nmol/l

0.12

120

863

Intestinal adhesions without obstruction

131

2.22

3.92

1.4

1.3

1.17

1.20

nmol/l

0.03

101

Injuries to the thorax

140

987

1.42

3.92

1.6

1.5

1.22

1.21

nmol/l

0.02

773

Benign neoplasm: Pancreas

3.46

3.91

1.6

1.4

0.89

1.02

nmol/l

0.33

Fracture of rib(s), sternum and thoracic spine

605

1.54

3.90

1.3

1.4

1.24

1.19

nmol/l

0.15

465

Delirium, not induced by alcohol and other psychoactive substances

164

2.08

3.90

1.3

1.10

1.12

nmol/l

0.03

125

Disorders of sclera, cornea, iris and ciliary body

171

1249

1.37

3.89

1.6

1.25

1.21

nmol/l

0.18

135

983

Pruritus

178

2.03

3.88

1.6

1.5

1.12

1.34

nmol/l

0.52

137

Alcohol abuse, main dg

321

1.75

3.86

1.3

1.5

1.07

1.16

nmol/l

0.28

250

Diplopia

227

1.90

3.86

1.5

1.4

1.16

1.18

nmol/l

0.02

178

Migraine

125

734

1.45

3.84

1.9

1.40

1.23

nmol/l

0.83

604

Asthma/COPD (KELA code 203)

305

1696

1.27

3.82

1.6

1.24

1.25

nmol/l

0.07

242

1340

Enlarged lymph nodes

278

1.80

3.82

1.5

1.25

1.23

nmol/l

0.05

215

Female genital prolapse

276

1.63

3.81

1.6

1.05

1.20

nmol/l

0.70

218

Acute peritonitis

101

2.39

3.81

2.5

1.4

0.88

1.21

nmol/l

1.36

Respiratory insufficiency

107

2.34

3.81

1.2

1.62

1.14

nmol/l

1.16

Corns and callosities

120

2.26

3.80

1.6

1.4

1.25

1.30

nmol/l

0.08

Mental retardation, wide definition

2.85

3.79

1.4

1.6

1.56

1.05

nmol/l

0.39

Benign neoplasm of other and ill-defined parts of digestive system

316

1.75

3.77

1.6

1.4

1.19

1.25

nmol/l

0.20

240

Hyperparathyroidism

305

1.75

3.76

1.3

1.50

1.17

nmol/l

1.10

232

Other viral diseases

561

1.55

3.76

1.7

1.8

1.35

1.22

nmol/l

0.51

447

Keratitis

110

748

1.47

3.75

1.5

1.6

1.30

1.24

nmol/l

0.21

594

Gonarthrosis [arthrosis of knee](FG)

258

1173

1.30

3.73

1.5

1.4

1.41

1.17

nmol/l

2.54

193

928

Weight loss

154

2.09

3.72

1.8

1.4

0.82

1.20

nmol/l

2.83

121

Iron deficiency anaemia secondary to blood loss (chronic)

266

1.81

3.72

1.4

1.3

1.65

1.20

nmol/l

1.03

207

Other problems related to primary support group, including family circumstances

183

1.98

3.71

1.5

2.0

1.25

1.35

nmol/l

0.16

151

Assault by bodily force

141

2.14

3.70

1.5

1.6

1.04

1.29

nmol/l

0.56

112

Paroxysmal tachycardia

230

1.80

3.67

1.7

1.46

1.23

nmol/l

0.54

188

Other disorders of the musculoskeletal system and connective tissue

260

1.81

3.67

1.4

1.3

1.35

1.15

nmol/l

0.55

199

Polyarthrosis

327

1.70

3.65

1.5

1.3

1.39

1.10

nmol/l

0.99

255

Noninfectious colitis NAS

246

1.84

3.65

1.2

1.5

1.21

1.25

nmol/l

0.09

188

Chronic viral hepatitis

2.43

3.64

1.5

1.8

1.56

1.21

nmol/l

0.42

Vulvovaginal ulceration/inflammation in other diseases

2.54

3.63

2.1

2.2

1.05

1.47

nmol/l

1.17

Abnormal results of function studies

149

2.09

3.62

1.1

1.4

1.23

nmol/l

0.00

120

Panic disorder

241

1.83

3.55

2.0

2.1

1.37

1.40

nmol/l

0.07

198

Event of undetermined intent

105

2.30

3.52

1.4

1.09

1.20

nmol/l

0.28

Hypopituitarism

118

2.21

3.50

1.7

1.5

1.70

1.25

nmol/l

1.19

Leisure time condition

316

1.71

3.50

1.5

1.6

1.11

1.23

nmol/l

0.47

243

Diverticular disease of intestine

211

1067

1.31

3.49

1.5

1.4

1.31

1.26

nmol/l

0.26

156

821

Schizoaffective disorder

138

2.11

3.49

1.7

1.5

1.08

1.28

nmol/l

0.51

111

Perforation of tympanic membrane

179

1.96

3.47

1.8

1.4

1.36

1.22

nmol/l

0.24

140

Parodontitis, under 40 years and operation codes

125

2.17

3.47

1.6

2.4

1.44

1.37

nmol/l

0.11

104

Parodontitis, operation under 40 years and operation codes

125

2.17

3.47

1.6

2.4

1.44

1.37

nmol/l

0.11

104

Use of pramipexole

401

1.63

3.46

1.4

1.3

1.42

1.21

nmol/l

0.78

301

All influenza (not pneumonia)

280

1.75

3.45

1.7

1.5

1.27

1.13

nmol/l

0.49

219

Other disorders of patella

340

1.68

3.45

2.4

1.7

1.26

1.18

nmol/l

0.25

267

COPD (mode)

491

1.51

3.45

1.3

1.46

1.18

nmol/l

1.23

367

Other otitis externa (chronic)

119

2.20

3.44

1.9

1.4

1.21

1.24

nmol/l

0.04

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

111

769

1.44

3.44

1.5

1.9

1.15

1.28

nmol/l

0.63

617

Mental retardation

2.77

3.42

1.3

1.7

1.64

1.07

nmol/l

0.40

Other viral hepatitis

113

2.22

3.41

1.5

1.6

1.44

1.27

nmol/l

0.19

Benign neoplasm of other and ill-defined parts of digestive system

326

1.69

3.41

1.6

1.4

1.19

1.26

nmol/l

0.22

256

Pneumonitis due to solids and liquids

126

2.15

3.41

1.2

1.3

1.00

1.09

nmol/l

0.17

Personal history of other diseases and conditions

152

2.04

3.41

1.8

2.1

1.58

1.48

nmol/l

0.10

127

Wet age-related macular degeneration

240

1.80

3.40

1.3

0.98

1.16

nmol/l

0.75

178

Streptococcal septicaemia

140

2.08

3.37

1.2

1.4

0.94

1.15

nmol/l

0.52

108

Colonic or urogenital fistula

562

1.52

3.37

1.8

1.4

1.22

1.19

nmol/l

0.06

434

Complications of internal orthopaedic prosthetic devices, implants and grafts

404

1.61

3.36

1.3

1.07

1.16

nmol/l

0.35

314

Zoster [herpes zoster]

320

1.69

3.36

1.4

1.3

1.32

1.23

nmol/l

0.19

244

conjunctival haemorrhage

114

2.20

3.35

1.3

1.4

0.96

1.08

nmol/l

0.20

Deforming dorsopathies

531

1.53

3.34

1.3

1.7

1.27

nmol/l

0.00

417

Other disorders of optic [2nd] nerve and visual pathways

108

2.23

3.32

1.7

1.4

1.33

1.27

nmol/l

0.08

Other disorders of veins

110

768

1.43

3.31

1.8

1.5

1.36

1.20

nmol/l

0.63

614

Generalized anxiety disorder

247

1.79

3.30

1.7

2.1

1.55

1.39

nmol/l

0.33

200

Gestational [pregnancy-induced] hypertension

413

1.60

3.30

2.7

2.0

1.63

1.31

nmol/l

1.18

338

Burns and corrosions of external body surface, specified by site

204

1.87

3.29

1.5

1.09

1.27

nmol/l

0.32

158

Fracture at wrist and hand level

110

771

1.43

3.25

1.5

1.6

1.11

1.21

nmol/l

0.58

601

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

354

1.64

3.24

1.1

1.3

1.02

1.23

nmol/l

1.11

272

Follow-up care involving plastic surgery

2.68

3.23

1.3

1.5

1.26

1.16

nmol/l

—

Superficial injury of head

393

1.61

3.22

1.6

1.23

1.24

nmol/l

0.00

308

Parodontitis, under 40 years

136

2.07

3.21

1.6

2.3

1.40

1.38

nmol/l

0.03

112

Parodontitis, under 40 years, or operation codes

136

2.07

3.21

1.6

2.3

1.40

1.38

nmol/l

0.03

112

ILD, hospital admission 2, with pulmonary infections

143

2.04

3.20

1.4

1.2

1.29

1.11

nmol/l

0.40

107

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

260

1.72

3.20

2.1

2.3

1.54

1.32

nmol/l

0.55

219

Symptoms and signs involving speech and voice

643

1.46

3.18

1.8

1.5

1.30

1.22

nmol/l

0.28

502

Other disorders of nervous system

117

2.15

3.16

1.3

1.4

1.10

1.22

nmol/l

0.20

Other shoulder lesions

144

2.02

3.15

1.3

1.4

0.97

1.36

nmol/l

0.95

112

Spondylolisthesis/Spondylolysis

334

1.65

3.14

1.5

1.35

1.28

nmol/l

0.16

259

Other diseases of arteries and capillaries

158

1.97

3.14

1.4

1.3

1.30

1.23

nmol/l

0.12

127

Other extrapyramidal and movement disorders in other diseases

412

1.58

3.13

1.5

1.3

1.05

1.22

nmol/l

0.67

312

Acute and transient psychotic disorders

216

1.81

3.08

1.8

1.5

1.06

1.22

nmol/l

0.53

168

Organic, including symptomatic, mental disorders

133

698

1.38

3.07

1.3

1.09

1.17

nmol/l

0.36

534

Noninflammatory disorders of female genital tract

107

372

1.45

3.06

2.0

1.9

1.44

1.26

nmol/l

0.67

298

Malignant neoplasm of respiratory system and intrathoracic organs

343

0.43

3.05

1.1

1.3

1.39

1.21

nmol/l

0.28

255

Other diseases of pleura

130

841

1.37

3.02

1.3

1.31

1.21

nmol/l

0.50

643

Other infectious diseases

133

2.04

3.01

1.8

1.4

1.04

1.18

nmol/l

0.28

102

Varicose veins

183

1060

1.31

3.00

1.3

1.4

1.15

1.21

nmol/l

0.41

137

833

Duodenal ulcer

161

1.93

2.98

1.2

1.3

1.26

1.14

nmol/l

0.23

127

Disorders of optic nerve and visual pathways

162

1.92

2.94

1.5

1.26

1.28

nmol/l

0.04

128

Fracture of shoulder and upper arm

104

737

1.41

2.93

1.3

1.6

1.11

1.21

nmol/l

0.38

564

Cervicalgia

388

1.58

2.92

1.7

1.5

1.19

1.24

nmol/l

0.11

298

Undetermined asthma, excluding more controls

184

1.85

2.90

1.4

1.6

1.28

1.22

nmol/l

0.09

136

Trigger finger

228

1.76

2.90

1.6

1.4

1.29

1.35

nmol/l

0.09

170

Ulcerative colitis

517

1.49

2.89

1.4

1.6

1.32

1.25

nmol/l

0.27

402

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

591

1.46

2.88

1.8

1.7

1.11

1.24

nmol/l

0.53

473

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

429

0.53

2.87

1.1

1.3

1.41

1.26

nmol/l

0.23

323

DVT of lower extremities and pulmonary embolism

117

847

1.38

2.87

1.4

1.41

1.17

nmol/l

1.14

651

Other arthritis (FG)

616

1.45

2.87

1.5

1.6

1.19

1.16

nmol/l

0.08

497

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

312

1.64

2.87

1.3

1.7

1.27

1.25

nmol/l

0.04

248

Other specified/unspecified arthritis

510

1.49

2.86

1.6

1.28

1.17

nmol/l

0.33

417

Disturbances of skin sensation

543

1.48

2.85

1.9

1.7

1.38

1.24

nmol/l

0.45

432

Conjunctivitis (acute, non atopic)

533

1.48

2.85

1.5

1.7

1.36

1.23

nmol/l

0.38

424

Preparation and fitting of bite rail to mouth

252

1.71

2.84

1.6

1.5

1.30

1.34

nmol/l

0.09

195

Leiomyoma of uterus

161

692

1.32

2.81

1.4

1.7

1.20

1.29

nmol/l

0.42

119

561

Other disorders of bone

392

1.56

2.81

1.5

1.6

1.20

1.28

nmol/l

0.26

298

Unspecified haematuria

125

787

1.36

2.81

1.2

1.4

1.48

1.23

nmol/l

1.16

605

Mental disorders, not otherwise specified

137

1.98

2.79

1.3

1.7

1.37

1.28

nmol/l

0.12

108

Explicit bacterial Sepsis

158

1.90

2.79

1.2

1.4

0.98

1.16

nmol/l

0.46

118

Disorders of refraction and accommodation

479

1.50

2.78

1.7

1.8

1.16

1.25

nmol/l

0.35

370

Provisional assignment of new diseases of uncertain etiology

128

949

1.35

2.77

1.8

1.7

1.28

1.25

nmol/l

0.11

109

750

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

500

1.49

2.77

1.5

2.0

1.30

1.32

nmol/l

0.06

402

Spondylosis

153

997

1.32

2.76

1.6

1.4

1.16

1.26

nmol/l

0.55

123

780

Codes for special purposes

128

950

1.35

2.76

1.8

1.7

1.28

1.24

nmol/l

0.12

109

751

Abnormal findings on diagnostic imaging of other body structures

232

1.73

2.75

1.4

1.34

1.22

nmol/l

0.29

183

Other inflammatory liver diseases

104

2.12

2.74

1.3

1.4

1.05

1.23

nmol/l

0.50

Superficial injury of thorax

270

1.67

2.74

2.0

1.4

1.29

1.17

nmol/l

0.27

208

Other noninflammatory disorders of vulva and perineum

118

2.04

2.71

1.5

1.8

1.36

1.26

nmol/l

0.12

Mental and behavioural disorders due to sedatives or hypnotics

125

2.01

2.70

1.2

1.5

0.65

1.27

nmol/l

3.28

102

Other secondary gonarthrosis

2.29

2.67

1.3

1.07

1.23

nmol/l

0.35

Malignant neoplasm of urinary organs

168

1.85

2.66

1.2

1.3

1.46

1.04

nmol/l

0.56

123

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

372

0.51

2.66

1.2

1.3

1.39

1.23

nmol/l

0.23

278

Systemic connective tissue disorders

669

1.41

2.63

1.6

1.5

1.20

1.23

nmol/l

0.09

522

Other disorders of conjunctiva

258

1.67

2.63

1.4

1.3

1.12

1.14

nmol/l

0.04

199

Viral meningitis

2.47

2.62

1.3

1.6

1.26

1.38

nmol/l

—

Acute alcohol intoxication

570

1.44

2.62

1.4

1.5

1.09

1.21

nmol/l

0.47

445

Ulcerative colitis (strict definition, require KELA)

328

1.59

2.61

1.3

1.7

1.26

1.24

nmol/l

0.04

257

Viral infections of the central nervous system

127

1.98

2.60

1.4

1.18

1.25

nmol/l

0.11

100

Cerebral palsy

4.04

2.57

1.4

1.6

1.96

0.92

nmol/l

—

Undetermined asthma

192

1.77

2.57

1.4

1.6

1.28

1.24

nmol/l

0.05

139

Migraine without aura

283

1.63

2.56

2.0

2.1

1.30

1.31

nmol/l

0.02

235

Herpesviral keratitis and keratoconjunctivitis

2.37

2.56

1.2

1.5

1.06

1.22

nmol/l

0.18

Fracture of lumbar spine and pelvis

385

1.53

2.55

1.2

1.3

1.19

1.20

nmol/l

0.02

295

Other noninflammatory disorders of uterus, except cervix

217

1.61

2.53

1.5

1.4

1.38

1.13

nmol/l

0.73

166

Other disorders of eyelid

117

840

1.35

2.52

1.3

1.23

1.20

nmol/l

0.08

644

Injury of muscle and tendon at shoulder and upper arm level

112

828

1.36

2.52

1.2

1.4

1.31

1.21

nmol/l

0.43

638

Other arrhythmias

184

1110

1.27

2.51

1.6

1.22

1.25

nmol/l

0.13

146

876

Other bursopathies

216

1.72

2.51

1.6

1.3

1.15

1.28

nmol/l

0.38

158

Inflammatory disease of uterus

216

1.72

2.51

1.9

2.0

1.45

1.38

nmol/l

0.13

174

Nonischemic cardiomyopathy

2.17

2.51

1.2

1.3

1.74

1.15

nmol/l

0.71

Other mental disorders due to brain damage and dysfunction and to physical disease

179

1.79

2.51

1.3

0.99

1.15

nmol/l

0.29

141

COPD

131

815

1.33

2.51

1.4

1.3

1.38

1.23

nmol/l

0.71

618

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

115

2.01

2.51

1.4

1.3

1.22

1.16

nmol/l

0.11

Convalescence

2.12

2.49

2.1

1.5

1.17

1.23

nmol/l

0.11

Other chronic obstructive pulmonary disease

126

787

1.33

2.48

1.3

1.41

1.21

nmol/l

0.97

597

Other disorders of cornea

165

1.82

2.48

1.4

1.36

1.22

nmol/l

0.30

133

Other systemic involvement of connective tissue (FG)

459

1.47

2.46

1.4

1.5

1.19

1.18

nmol/l

0.02

363

Haemorrhoids and perianal venous thrombosis

536

1.44

2.45

1.4

1.36

1.19

nmol/l

0.61

413

ILD, hospital admissions

248

1.66

2.45

1.6

1.3

1.23

1.18

nmol/l

0.11

186

Cerebral palsy and other paralytic syndromes

203

1.73

2.44

1.5

1.3

1.64

1.20

nmol/l

0.94

155

Nonorganic sleeping disorders

351

1.54

2.41

1.5

1.7

1.30

1.33

nmol/l

0.07

278

Alcohol withdrawal state with delirium

138

1.89

2.41

1.4

1.3

1.09

1.11

nmol/l

0.03

102

ILD, hospital admissions 3, with pneumonia sepsis

131

1.92

2.40

1.3

1.31

1.06

nmol/l

0.51

Pyogenic arthritis

117

1.97

2.40

1.3

1.2

1.07

1.08

nmol/l

0.00

Other hearing loss

473

1.46

2.39

1.5

1.3

1.23

nmol/l

0.02

362

Radiculopathy

289

1.60

2.38

1.1

1.4

1.15

1.26

nmol/l

0.32

218

5-aminosalicylic acid

433

1.48

2.38

1.5

1.6

1.23

1.26

nmol/l

0.13

339

Leiomyoma of uterus

124

523

1.34

2.37

1.5

1.8

1.22

1.34

nmol/l

0.52

431

Drug-induced adrenocortical insufficiency

3.67

2.37

1.3

1.8

2.88

0.87

nmol/l

—

Other specified and unspecified retinal disorders

2.62

2.36

1.4

0.61

1.34

nmol/l

—

Haemorrhage in early pregnancy

415

1.48

2.36

2.0

1.8

1.48

1.30

nmol/l

0.62

339

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

118

1.96

2.35

1.4

1.3

1.22

1.17

nmol/l

0.08

Other obstructed labour

111

1.99

2.35

1.2

1.8

1.29

1.43

nmol/l

0.18

Other endocrine disorders

2.27

2.35

1.3

1.8

1.47

1.07

nmol/l

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

2.27

2.34

2.4

1.5

0.97

1.48

nmol/l

—

Gonarthrosis,primary

273

1421

1.21

2.34

1.5

1.4

1.36

1.22

nmol/l

1.28

208

1112

Dentofacial anomalies [including malocclusion]

503

1.44

2.34

1.8

1.00

1.27

nmol/l

1.53

414

Interstitial lung disease endpoints

252

1.63

2.32

1.6

1.3

1.23

1.18

nmol/l

0.11

189

Interstitial lung disease

252

1.63

2.32

1.6

1.3

1.23

1.18

nmol/l

0.11

189

Dislocation, sprain and strain of joints and ligaments of knee

179

1325

1.26

2.31

1.5

1.7

1.37

1.25

nmol/l

0.81

143

1064

Tubulo-interstitial nephritis, not specified as acute or chronic

105

2.01

2.30

1.1

1.4

1.13

1.26

nmol/l

0.18

Other infective otitis externa

112

1.97

2.30

2.0

1.4

1.29

1.27

nmol/l

0.02

Faecal incontinence

126

1.91

2.30

1.6

1.4

1.18

1.24

nmol/l

0.12

101

Other and unspecified mood [affective] disorders

112

1.97

2.30

1.6

2.1

1.30

1.33

nmol/l

0.03

Other predominantly sexually transmitted diseases, not elsewhere classified

300

1.57

2.29

1.9

2.0

1.47

1.37

nmol/l

0.19

243

Venous thromboembolism

151

1148

1.28

2.27

1.4

1.36

1.21

nmol/l

0.77

114

888

Other interstitial pulmonary diseases

254

1.62

2.26

1.6

1.3

1.23

1.18

nmol/l

0.11

191

Glucosamine medication

858

0.72

2.26

1.4

1.3

1.26

1.20

nmol/l

0.17

655

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

216

1.67

2.25

1.2

1.3

1.55

1.24

nmol/l

0.41

161

Disorders of vestibular function (Vertigo)

127

968

1.30

2.25

1.6

1.5

1.21

1.20

nmol/l

0.05

761

Urticaria and erythema

725

1.35

2.23

1.9

1.7

1.20

1.27

nmol/l

0.26

576

Viral hepatitis

142

1.84

2.23

1.5

1.6

1.38

1.24

nmol/l

0.16

118

Open wound of wrist and hand

132

1010

1.30

2.22

1.5

1.6

1.17

1.25

nmol/l

0.35

795

Ocular pain

135

1.86

2.22

1.9

1.4

0.97

1.29

nmol/l

0.61

107

Maternal care for other known or suspected fetal problems

242

1.51

2.21

2.8

2.1

1.17

1.48

nmol/l

1.29

208

Acute and subacute iridocyclitis

375

1.50

2.21

1.6

1.5

1.25

nmol/l

0.00

290

Malignant neoplasm of kidney, except renal pelvis

157

1.79

2.21

1.2

1.3

1.44

1.04

nmol/l

0.44

116

Asthma, hospital admissions , main diagnosis only

240

1777

1.21

2.20

1.6

1.28

1.25

nmol/l

0.17

191

1398

Synovial cyst of popliteal space [Baker]

100

2.01

2.20

1.8

1.3

1.25

1.21

nmol/l

—

Disorders resulting from impaired renal tubular function

2.42

2.20

1.0

1.5

1.32

1.26

nmol/l

—

Type1 diabetes, definitions combined, early onset

2.04

2.19

3.6

2.0

0.51

1.31

nmol/l

4.03

Gingival hyperplasia

2.51

2.19

2.3

1.4

1.82

1.15

nmol/l

0.83

Other medical care

719

1.35

2.18

1.4

1.5

1.05

1.25

nmol/l

1.44

554

Trochanteric bursitis

203

1.68

2.17

1.5

1.4

1.20

1.27

nmol/l

0.11

153

Paracetamol of NSAID medication

185

1.53

2.16

1.5

1.6

1.29

1.13

nmol/l

0.49

150

Complications of labour and delivery

148

643

1.28

2.16

1.9

1.7

1.29

1.38

nmol/l

0.42

121

515

Iridocyclitis

460

1.44

2.14

1.5

1.30

1.26

nmol/l

0.12

357

Myeloproliferative diseases

144

1.81

2.14

1.2

1.4

1.26

1.20

nmol/l

0.12

113

DVT of lower extremities

362

1.49

2.13

1.5

1.3

1.53

1.19

nmol/l

0.82

281

Unspecified acute lower respiratory infection

298

1.55

2.13

1.8

1.5

1.28

1.15

nmol/l

0.37

233

Benign lipomatous neoplasm

629

1.37

2.12

1.6

1.4

1.21

nmol/l

0.01

487

Radial styloid tenosynovitis [de Quervain]

2.11

2.12

1.3

1.5

1.16

1.30

nmol/l

—

Myeloproliferative diseases (CML excluded)

130

1.85

2.12

1.3

1.35

1.18

nmol/l

0.36

101

Insomnia

283

1.56

2.10

1.4

1.7

1.39

1.36

nmol/l

0.06

225

Benign paroxysmal vertigo

555

1.39

2.08

1.5

1.4

1.29

1.22

nmol/l

0.19

431

Other chronic obstructive pulmonary disease, including avohilmo

154

1016

1.26

2.08

1.4

1.3

1.34

1.21

nmol/l

0.67

111

773

Inflammatory bowel disease

700

1.34

2.08

1.5

1.6

1.28

1.26

nmol/l

0.08

546

Injury of eye and orbit

268

1.57

2.08

1.8

1.7

1.07

1.26

nmol/l

0.66

209

Benign lipomatous neoplasm

632

1.36

2.07

1.6

1.5

1.21

1.19

nmol/l

0.08

488

Atopic dermatitis, strict definition with reimbursement

563

1.38

2.07

1.9

1.19

1.33

nmol/l

0.55

450

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

404

0.57

2.07

1.4

1.5

1.17

1.25

nmol/l

0.17

325

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

191

1.68

2.06

1.2

1.3

1.45

1.24

nmol/l

0.22

144

Malignant neoplasm of breast, HER-negative

367

0.54

2.04

1.3

1.5

0.93

1.23

nmol/l

0.81

285

Complications predominantly related to the puerperium

449

1.43

2.02

2.0

1.37

1.35

nmol/l

0.06

370

Puerperal sepsis

223

1.62

2.02

1.8

1.6

1.64

1.29

nmol/l

0.64

179

Allergic contact dermatitis

239

1.59

2.01

2.0

1.6

1.21

1.36

nmol/l

0.49

189

Benign neoplasm: Descending colon

104

1.93

2.00

1.2

1.4

1.12

1.13

nmol/l

0.01

Other benign neoplasms of skin

101

766

1.32

1.99

1.4

1.5

1.09

1.21

nmol/l

0.54

602

Dental pulpitis 3

110

1.77

1.98

2.5

2.9

1.52

1.47

nmol/l

0.06

Idiopathic gout

156

1.74

1.96

1.1

1.3

1.67

1.04

nmol/l

1.78

112

Polyp of the female genital tract

298

1.41

1.95

1.6

1.7

1.39

1.21

nmol/l

0.67

234

Abnormal findings on antenatal screening of mother

2.03

1.95

2.8

2.3

1.23

1.46

nmol/l

0.39

Retention of urine

604

1.33

1.95

1.3

1.08

1.21

nmol/l

0.52

463

Injuries to unspecified part of trunk, limb or body region

179

1.68

1.95

1.6

1.4

1.08

1.22

nmol/l

0.24

141

Other and unspecified myopathies

149

1.75

1.94

1.3

1.80

1.07

nmol/l

1.53

113

Urticaria

580

1.36

1.94

1.9

1.8

1.20

1.24

nmol/l

0.11

464

Injury of unspecified body region

127

1.82

1.93

1.1

1.4

0.96

1.16

nmol/l

0.36

100

Early lumbar disc prolapse, operated

187

1.66

1.93

1.4

1.8

1.12

1.31

nmol/l

0.52

145

Lung diseases due to external agents

234

1.58

1.92

1.2

1.3

1.14

1.18

nmol/l

0.07

176

Malignant neoplasm of breast

719

0.73

1.90

1.2

1.6

1.38

1.27

nmol/l

0.41

576

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

1.93

1.90

1.1

1.4

0.93

1.08

nmol/l

0.49

Other disorders of amniotic fluid and membranes

194

1.64

1.89

2.6

2.0

1.26

1.43

nmol/l

0.44

166

Malignant neoplasm of breast, HER2-negative

705

0.73

1.88

1.2

1.5

1.33

1.25

nmol/l

0.26

563

Pulmonary heart disease, diseases of pulmonary circulation

601

1.35

1.86

1.4

1.3

1.33

1.21

nmol/l

0.45

460

Meniscus derangement

171

951

1.23

1.86

1.6

1.4

1.26

1.16

nmol/l

0.58

136

762

Childhood asthma (age<16), excluding more controls

161

1.63

1.85

2.2

2.5

1.41

1.33

nmol/l

0.09

129

Other and unspecified urticaria

367

1.45

1.83

1.9

1.7

1.26

1.28

nmol/l

0.03

289

Viral pneumonia (unknown virus, not influenza)

115

1.83

1.82

1.7

1.4

1.01

1.27

nmol/l

0.42

Childhood asthma (age<16)

162

1.62

1.82

2.2

2.5

1.41

1.36

nmol/l

0.06

131

Endometriosis

350

1.36

1.81

1.8

1.36

1.25

nmol/l

0.37

278

TMD related pain

2.28

1.81

2.6

1.7

1.51

1.30

nmol/l

—

Other necrotizing vasculopathies (FG)

101

1.89

1.80

2.4

1.2

1.24

1.17

nmol/l

0.11

Sequelae of other external causes

1.92

1.80

1.5

0.90

1.26

nmol/l

1.09

Lyme disease

513

0.64

1.79

1.7

1.4

1.13

1.22

nmol/l

0.18

401

Pulmonary embolism

554

1.36

1.79

1.4

1.3

1.33

1.19

nmol/l

0.47

428

Infections with a predominantly sexual mode of transmission

614

1.34

1.79

2.1

1.9

1.31

nmol/l

0.01

489

Chronic sinusitis

119

938

1.27

1.78

1.8

1.6

1.32

1.23

nmol/l

0.36

737

Other fall from one level to another

436

1.40

1.78

1.4

1.7

1.31

1.23

nmol/l

0.22

343

COPD, early/later onset

126

843

1.26

1.77

1.3

1.41

1.19

nmol/l

1.16

650

Eustachian salpingitis and obstruction

131

1.76

1.77

2.2

1.7

1.72

1.18

nmol/l

0.79

106

Adjustment and management of implanted device

288

1.50

1.76

1.1

1.3

1.29

1.18

nmol/l

0.24

222

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

362

1.44

1.76

1.3

1.6

1.26

1.22

nmol/l

0.09

281

Pulmonary heart disease

556

1.35

1.76

1.4

1.3

1.33

1.19

nmol/l

0.47

429

Other disorders of eye and adnexa

240

1.55

1.75

1.7

1.5

0.91

1.24

nmol/l

0.97

188

Other systemic involvement of connective tissue

514

1.36

1.75

1.4

1.5

1.18

1.26

nmol/l

0.26

400

Other disorders of white blood cells

1.94

1.75

1.2

1.4

1.47

1.19

nmol/l

0.31

Coagulation defects, purpura and other haemorrhagic conditions

346

1.45

1.74

1.4

1.5

1.27

1.26

nmol/l

0.03

269

COPD, hospital admissions

125

840

1.26

1.74

1.4

1.3

1.41

1.19

nmol/l

1.16

646

Other and unspecified epidermal thickening

2.51

1.74

1.8

1.7

0.97

1.22

nmol/l

—

Thyroiditis, ILD-related definition

193

1.61

1.74

2.3

1.5

1.24

1.32

nmol/l

0.12

152

Other follicular disorders

132

1.75

1.73

2.3

1.5

1.44

1.24

nmol/l

0.29

105

Acute pharyngitis

279

1.50

1.73

1.8

1.9

1.17

1.30

nmol/l

0.38

218

Benign neoplasm: Descending colon

110

1.83

1.73

1.2

1.4

1.12

1.20

nmol/l

0.11

Anterior Iridocyclitis

397

1.41

1.72

1.6

1.5

1.25

nmol/l

0.01

306

Symptoms and signs involving the skin and subcutaneous tissue

191

1585

1.20

1.71

1.6

1.23

1.26

nmol/l

0.15

143

1250

Ganglion

373

1.42

1.70

1.2

1.7

1.51

1.32

nmol/l

0.50

294

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

118

1.79

1.70

1.5

1.7

0.56

1.22

nmol/l

2.32

Retinal vascular occlusion

171

1.64

1.70

1.1

1.3

1.05

1.27

nmol/l

0.77

131

Erosion of teeth, including avohilmo

393

1.40

1.68

1.4

1.8

1.15

1.25

nmol/l

0.33

325

Budesonide

251

1.52

1.67

1.6

1.5

1.14

1.29

nmol/l

0.40

194

Retinal vascular disorders

172

1.63

1.66

1.1

1.3

1.05

1.26

nmol/l

0.76

132

malignant neoplasm of male genital organs

655

0.76

1.66

1.2

1.26

1.22

nmol/l

0.09

488

Medical abortion

153

675

1.23

1.66

1.8

1.9

1.38

1.32

nmol/l

0.28

127

541

TMD related operations

317

1.45

1.65

1.6

1.28

1.33

nmol/l

0.10

247

Other condition

261

1.50

1.62

1.6

1.5

1.41

1.21

nmol/l

0.48

201

ILD, hospital admissions 1, main diag only

221

1.54

1.61

1.4

1.3

1.34

1.16

nmol/l

0.40

163

COPD, hospital admission 2, with asthma infections

547

1.31

1.61

1.3

1.35

1.17

nmol/l

0.71

411

Atopic dermatitis, strict definition

545

1.33

1.61

1.9

2.0

1.21

1.33

nmol/l

0.45

436

severe traumatic brain injury, does not include concussion

404

1.39

1.58

1.4

1.3

1.24

1.16

nmol/l

0.22

306

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

513

0.74

1.57

1.2

1.3

1.34

1.27

nmol/l

0.15

377

Diseases of inner ear

144

1156

1.22

1.56

1.6

1.5

1.19

1.21

nmol/l

0.09

107

901

Schizophrenia

313

1.44

1.56

1.3

1.5

1.14

1.19

nmol/l

0.12

241

Pilonidal cyst

160

1.63

1.55

1.4

1.6

1.46

1.36

nmol/l

0.11

124

Allergic asthma (mode), excluding more controls

415

1.37

1.54

2.3

1.9

1.24

nmol/l

0.00

333

Paralytic strabismus

122

1.73

1.54

1.2

1.4

0.92

1.14

nmol/l

0.41

Female infertility

327

1.34

1.53

2.2

1.9

1.61

1.27

nmol/l

1.24

262

Allergic asthma (mode)

416

1.37

1.52

2.3

1.9

1.24

nmol/l

0.01

332

Other and unspecified vascular occlusions

138

1.67

1.51

1.1

1.2

1.05

1.18

nmol/l

0.40

108

Ptosis of eyelid

185

1.57

1.51

1.1

1.3

1.54

1.15

nmol/l

0.76

142

Psoriatic and enteropathic arthropathies

217

1.52

1.51

1.7

1.3

1.51

1.13

nmol/l

0.92

166

Deficiency of other B group vitamins

2.87

1.51

1.8

0.46

0.98

nmol/l

—

Other necrotizing vasculopathies

123

1.71

1.50

2.2

1.3

1.16

1.12

nmol/l

0.06

Dermatophytosis

242

1.49

1.3

1.31

1.20

nmol/l

0.26

188

Ulcerative colitis (strict definition, all Crohn cases excluded)

275

1.46

1.48

1.4

1.6

1.34

1.27

nmol/l

0.19

212

Deviated nasal septum

784

1.26

1.48

1.5

1.47

1.24

nmol/l

1.02

616

IBD patients in KELA-register

478

1.34

1.48

1.4

1.7

1.22

1.25

nmol/l

0.09

373

Benign neoplasm of ovary

319

0.59

1.48

1.3

1.5

1.11

1.24

nmol/l

0.20

256

Early lumbar disc prolapse operation

202

1.54

1.48

1.4

1.6

1.12

1.35

nmol/l

0.69

163

Other and unspecified disorders of vitreous body

103

816

1.26

1.48

1.7

1.3

1.15

1.21

nmol/l

0.22

628

Strabismus

495

1.33

1.47

1.6

1.7

1.24

1.28

nmol/l

0.10

387

Coxarthrosis

139

773

1.22

1.46

1.3

1.14

1.17

nmol/l

0.16

611

Abscess of anal and rectal regions

171

1.58

1.45

1.3

1.4

0.90

1.25

nmol/l

2.05

135

Acetic acid derivatives and related substances

341

1.30

1.44

1.4

1.10

1.18

nmol/l

0.29

276

Immunodeficiencies

1.88

1.44

1.4

1.6

1.17

1.21

nmol/l

—

Allergic urticaria

140

1.65

1.44

1.7

1.5

1.23

1.29

nmol/l

0.08

110

Corneal ulcer

352

1.39

1.44

1.7

1.6

1.20

1.24

nmol/l

0.09

275

Disorders of conjunctiva

227

1635

1.16

1.44

1.7

1.29

1.25

nmol/l

0.24

173

1294

Parapsoriasis

2.74

1.43

1.2

1.7

1.27

0.88

nmol/l

—

Fentanyl

148

1.62

1.43

1.7

1.3

0.71

1.24

nmol/l

1.93

113

Other spirochaetal diseases

520

0.69

1.42

1.6

1.4

1.23

1.22

nmol/l

0.01

407

Other benign neoplasms of skin

101

792

1.25

1.42

1.4

1.5

1.09

1.22

nmol/l

0.67

614

Inflammatory bowel disease, strict (require KELA)

482

1.33

1.41

1.4

1.7

1.22

1.24

nmol/l

0.07

377

Tonsillectomy and adenotomy

157

912

1.20

1.40

2.1

1.8

1.31

1.26

nmol/l

0.22

126

732

Pregnancy with abortive outcome

157

682

1.20

1.40

1.9

1.36

1.32

nmol/l

0.16

124

546

Migraine, single triptan purchase ok & required. ICD-code if available is included

164

1319

0.84

1.40

1.9

1.7

1.41

1.24

nmol/l

1.22

133

1050

Triptan medication for migraine, single purchase ok

164

1319

0.84

1.40

1.9

1.7

1.41

1.24

nmol/l

1.22

133

1050

Psoriatic arthropathies

181

1.55

1.39

1.8

1.2

1.54

1.11

nmol/l

0.87

136

Superficial injury of hip and thigh

254

1.46

1.39

1.4

1.3

0.99

1.22

nmol/l

0.97

200

Other specific arthropathies, wide

2.43

1.39

2.1

1.4

1.42

1.13

nmol/l

—

Urethral stricture

1.78

1.39

1.1

1.4

1.20

1.09

nmol/l

0.18

Acute otitis externa, noninfective

2.62

1.37

1.0

1.9

1.00

1.08

nmol/l

—

Impacted cerumen

166

1.57

1.37

1.4

1.3

2.14

1.10

nmol/l

—

129

Disorder of the sleep-wake schedule

2.62

1.37

1.2

1.8

1.21

1.19

nmol/l

—

Entropion and trichiasis of eyelid

127

1.66

1.36

1.5

1.4

1.53

1.02

nmol/l

0.83

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

491

0.76

1.36

1.2

1.3

1.34

1.26

nmol/l

0.16

358

Aneurysms, operations, SAH

281

1.43

1.35

1.5

1.4

1.00

1.18

nmol/l

0.59

218

Glaucoma suspect

706

1.26

1.35

1.4

1.3

1.25

1.18

nmol/l

0.26

545

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

0.00

1.34

0.0

1.2

—

1.22

—

FESS (DNB20)

240

1.46

1.34

1.9

1.3

1.52

1.19

nmol/l

0.79

184

Malignant neoplasm of prostate

629

0.78

1.34

1.2

1.26

1.22

nmol/l

0.10

466

Injury of intra-abdominal organs

2.15

1.34

1.1

1.6

0.94

1.17

nmol/l

—

ILD medications: azathioprine

265

1.44

1.33

1.6

1.21

1.27

nmol/l

0.11

210

Abnormal serum enzyme levels

654

1.27

1.33

1.3

1.37

1.23

nmol/l

0.47

488

COPD, hospital admissions 1, only main diagnosis

601

1.26

1.33

1.4

1.3

1.40

1.19

nmol/l

0.80

454

Superficial injury of abdomen, lower back and pelvis

274

1.43

1.32

1.5

1.7

1.48

1.28

nmol/l

0.29

217

Other enthesopathy of foot (+metatarsalgia)

152

1.58

1.31

1.4

1.26

1.30

nmol/l

0.08

115

Disorders of muscles

152

1.58

1.31

1.4

1.64

1.24

nmol/l

0.56

117

Procreative management

589

1.26

1.31

2.2

1.7

1.20

1.21

nmol/l

0.04

464

Endometriosis of ovary

249

1.44

1.31

1.9

1.8

0.92

1.16

nmol/l

1.00

198

All dysplastic lesions of the vagina

2.10

1.30

2.9

1.8

1.25

1.36

nmol/l

—

Benign neoplasm of ovary

307

0.62

1.30

1.3

1.4

1.11

1.25

nmol/l

0.24

244

Postmenopausal bleeding

237

1.35

1.29

1.5

1.63

1.18

nmol/l

1.79

183

Glomerulonephritis

185

1.52

1.28

1.2

1.4

1.81

1.23

nmol/l

0.78

144

Propionic acid derivatives

353

1.27

1.28

1.6

1.5

1.26

1.16

nmol/l

0.37

286

Right bundle-branch block

1.94

1.28

1.1

1.4

1.38

1.10

nmol/l

—

Umbilical hernia

614

1.27

1.28

1.6

1.4

1.19

1.23

nmol/l

0.12

483

Hyperplasia of prostate

113

525

1.23

1.27

1.3

1.10

1.27

nmol/l

0.75

398

Contact with other sharp object(s)

122

1.64

1.27

1.5

1.43

1.36

nmol/l

0.10

Long labour

322

1.36

1.27

2.6

2.0

1.29

1.36

nmol/l

0.16

266

Mandibular retrognathia AND surgery (BSSRO)

2.30

1.27

1.3

1.9

1.42

1.46

nmol/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

424

1.31

1.27

1.2

1.3

1.41

1.18

nmol/l

0.75

320

135

0.44

1.27

1.0

2.4

1.60

1.61

nmol/l

—

114

Foreign body on external eye

336

1.37

1.26

1.5

1.00

1.16

nmol/l

0.67

259

Hypertrophy of breast

294

1.40

1.25

2.0

1.9

1.27

1.32

nmol/l

0.09

239

Nonsuppurative otitis media

335

1.34

1.24

2.1

2.0

1.67

1.22

nmol/l

1.33

270

Inguinal hernia

138

1107

0.84

1.23

1.7

1.4

1.24

1.22

nmol/l

0.04

105

866

Contact with and exposure to communicable diseases

616

0.74

1.22

1.7

2.1

0.99

1.33

nmol/l

2.39

496

Mature T/NK-cell lymphomas, hilmo

2.65

1.22

1.2

1.7

0.62

0.87

nmol/l

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

583

0.78

1.21

1.3

1.6

1.37

1.30

nmol/l

0.22

475

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

583

0.78

1.21

1.3

1.6

1.37

1.30

nmol/l

0.22

475

Suppurative otitis media, unspecified

2.17

1.21

2.5

1.5

0.84

1.14

nmol/l

—

Polymyalgia rheumatica

213

1.46

1.20

1.1

1.2

1.15

1.12

nmol/l

0.05

160

Benign neoplasm: Skin of eyelid, including canthus

281

1.39

1.18

1.6

1.4

1.41

1.23

nmol/l

0.48

221

Cervicocranial syndrome

173

1.51

1.17

1.7

1.5

1.39

1.33

nmol/l

0.09

132

Focal epilepsy, strict definition

367

1.34

1.17

1.7

1.4

1.06

1.18

nmol/l

0.54

278

Thyrotoxicosis with diffuse goitre

231

1.43

1.17

2.0

1.5

1.31

1.38

nmol/l

0.12

180

Glaucoma

140

1039

1.18

1.16

1.4

1.20

1.22

nmol/l

0.03

801

Hyperprolactinaemia

2.01

1.16

1.7

1.6

1.07

1.39

nmol/l

—

Malignant neoplasm of testis

0.00

1.16

0.0

1.2

—

1.11

—

Benign neoplasm: Skin of eyelid, including canthus

282

1.39

1.16

1.6

1.4

1.41

1.20

nmol/l

0.57

216

Dislocation, sprain and strain of joints and ligaments at neck level

282

1.39

1.16

1.9

1.7

1.28

1.32

nmol/l

0.06

227

Acute appendicitis, with complications

427

0.70

1.14

1.3

1.5

1.07

1.20

nmol/l

0.39

325

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

115

841

1.20

1.14

1.3

1.4

1.13

1.26

nmol/l

0.79

642

Chalazion

216

1.44

1.13

1.9

1.5

0.88

1.25

nmol/l

1.57

165

Ethmoidectomy

258

1.40

1.13

1.9

1.3

1.51

1.20

nmol/l

0.76

196

Macular hole

1.76

1.13

1.8

1.2

1.27

1.09

nmol/l

—

Macular pucker

233

1.42

1.12

1.4

1.2

0.91

1.21

nmol/l

1.42

178

Other conjunctival vascular disorders and cysts

2.34

1.12

1.3

1.5

1.31

1.14

nmol/l

—

Enthesopathies of lower limb, excluding foot

422

1.30

1.12

1.5

1.7

1.02

1.28

nmol/l

1.54

332

Corneal scars and opacities

2.01

1.12

1.0

1.6

1.20

1.23

nmol/l

—

Other menopausal disorders

260

0.71

1.11

1.9

1.5

1.51

1.18

nmol/l

0.70

205

Arterial embolism and thrombosis

1.71

1.11

1.1

1.3

1.17

1.09

nmol/l

—

Other viral diseases, not elsewhere classified

345

1.33

1.08

1.7

1.45

1.30

nmol/l

0.48

274

Idiopathic pulmonary fibrosis

120

1.59

1.08

1.2

1.3

1.03

1.10

nmol/l

0.19

Dementia, including avohilmo

537

1.22

1.08

1.3

1.13

1.16

nmol/l

0.07

408

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

787

0.82

1.08

1.2

1.4

0.99

1.25

nmol/l

2.13

601

Coxibs

342

1.25

1.06

1.6

1.5

1.20

1.18

nmol/l

0.05

277

Focal epilepsy

409

1.30

1.05

1.7

1.5

1.08

1.22

nmol/l

0.69

314

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

797

0.83

1.05

1.2

1.4

0.99

1.25

nmol/l

2.22

608

Aortic aneurysm

422

0.72

1.03

1.5

1.2

1.23

1.17

nmol/l

0.10

326

Other lack of coordination

2.28

1.03

1.2

1.7

1.52

1.21

nmol/l

—

Toxic effects of substances chiefly nonmedicinal as to source

212

1.42

1.03

1.4

1.5

1.39

1.27

nmol/l

0.29

163

Asthma and allergy, excluding more controls

201

1.43

1.03

2.5

2.3

1.34

1.25

nmol/l

0.16

160

Asthma and allergy

201

1.43

1.03

2.5

2.3

1.34

1.28

nmol/l

0.11

160

Benign neoplasm: Transverse colon

171

1.47

1.02

1.2

1.3

1.08

1.12

nmol/l

0.10

128

Superficial injury of forearm

163

1.48

1.01

2.3

1.7

1.37

1.28

nmol/l

0.10

132

Alzheimer disease, excluding more controls

135

1.44

1.01

1.1

1.3

1.33

1.22

nmol/l

0.20

111

Congenital malformations and deformations of the musculoskeletal system

138

1.52

1.00

2.2

1.8

1.36

1.31

nmol/l

0.06

112

Other noninflammatory disorders of cervix uteri

1.77

1.00

1.3

1.4

1.78

1.27

nmol/l

—

Effects of foreign body entering through natural orifice

528

1.25

1.00

1.4

1.6

1.36

1.19

nmol/l

0.44

414

Uterine polyps

139

1.51

1.00

1.5

1.30

1.12

nmol/l

0.29

109

Azathioprine

282

1.35

0.99

1.6

1.21

1.29

nmol/l

0.13

220

Dental caries 3 and operation codes, only avohilmo

366

1.22

0.99

1.5

1.6

1.29

1.23

nmol/l

0.21

281

Pedestrian injured in transport accident

115

1.57

0.99

1.8

1.4

0.74

1.23

nmol/l

1.95

Mucosal proctocolitis

248

1.37

0.99

1.3

1.6

1.32

1.29

nmol/l

0.07

191

L02BA Anti-estrogens

285

0.67

0.98

1.1

1.5

1.76

1.24

nmol/l

0.98

223

Benign neoplasm: Conjunctiva

1.84

0.98

2.3

1.6

1.26

1.21

nmol/l

—

Benign neoplasm: Conjunctiva

1.84

0.98

2.3

1.6

1.26

1.31

nmol/l

—

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

2.19

0.98

1.2

1.7

0.62

1.09

nmol/l

—

Cardiomyopathy, Hypertrophic obstructive

0.00

0.97

0.0

1.5

—

1.14

—

Extrapyramidal and movement disorders

720

1.21

0.97

1.6

1.4

1.14

1.22

nmol/l

0.26

560

Retinal detachments and breaks

666

1.22

0.97

1.4

1.3

1.06

1.23

nmol/l

0.97

521

Salpingitis and oophoritis

310

1.32

0.96

2.2

1.6

1.40

1.28

nmol/l

0.26

252

Injuries to the hip and thigh

115

894

1.18

0.96

1.4

1.5

1.07

1.25

nmol/l

1.14

685

Presbycusis

206

1.40

0.96

1.4

1.2

1.24

1.11

nmol/l

0.22

156

Second line medication for Crohn's disease

150

1303

1.15

0.95

1.4

1.6

1.35

1.23

nmol/l

0.57

116

1023

Embedded teeth, including avohilmo

141

1.49

0.94

2.1

1.15

1.46

nmol/l

0.47

116

Otalgia

133

1.51

0.94

3.1

1.5

1.45

1.24

nmol/l

0.31

108

Other peripheral vertigo

166

1.45

0.94

2.0

1.3

1.35

1.15

nmol/l

0.34

133

Adverse effects, not elsewhere classified

355

1.30

0.94

1.3

1.8

1.23

1.32

nmol/l

0.23

280

Nontoxic single thyroid nodule

125

1.52

0.94

2.2

1.5

0.99

1.30

nmol/l

0.52

Primary coxarthrosis, bilateral

543

1.24

0.92

1.3

1.23

1.17

nmol/l

0.15

419

Labour and delivery complicated by fetal stress [distress]

224

1.31

0.92

2.6

2.1

1.35

1.45

nmol/l

0.27

185

In situ neoplasms

670

1.21

0.92

1.2

1.5

1.07

1.25

nmol/l

1.09

520

Injuries to the neck

427

1.27

0.92

1.7

1.09

1.26

nmol/l

0.44

340

Sudden idiopathic hearing loss

184

1.42

0.91

1.6

1.3

1.42

1.23

nmol/l

0.33

142

Psoriatic arthropathies, ICD10

201

1.40

0.91

1.8

1.4

1.54

1.22

nmol/l

0.60

158

Open wound of forearm

159

1.45

0.91

1.4

1.6

0.98

1.24

nmol/l

0.34

126

Inflammatory diseases of prostate (prostatitis)

261

1.34

0.91

1.3

0.97

1.17

nmol/l

0.64

200

Tooth eruption problems

199

1.39

0.91

2.0

2.2

1.15

1.41

nmol/l

0.50

162

Gonarthrosis, primary, with knee surgery

141

999

1.15

0.91

1.5

1.3

1.37

1.18

nmol/l

1.14

102

767

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

113

903

0.85

0.90

1.2

1.4

1.03

1.27

nmol/l

1.88

685

Fracture of skull and facial bones

420

1.26

0.89

1.4

1.6

1.10

1.22

nmol/l

0.43

335

Postpartum haemorrhage

334

1.28

0.89

3.5

2.1

1.70

1.39

nmol/l

0.97

275

Other degenerative diseases of the nervous system

297

1.28

0.89

1.5

1.4

1.21

1.22

nmol/l

0.03

243

Spinal enthesopathy

2.07

0.89

1.7

1.6

0.99

0.94

nmol/l

—

Foreign body entering into or through eye or natural orifice

160

1.44

0.88

1.3

1.5

1.57

1.18

nmol/l

0.62

123

Pleural plaque

160

1.44

0.88

1.3

1.40

1.09

nmol/l

0.67

115

Chronic rhinitis, nasopharyngitis and pharyngitis

638

1.21

0.87

1.5

1.6

1.17

1.23

nmol/l

0.26

510

Seropositive rheumatoid arthritis

474

1.24

0.87

1.3

1.4

1.43

1.13

nmol/l

1.05

372

Cerebral aneurysm, nonruptured

144

1.46

0.87

1.5

1.4

1.16

1.24

nmol/l

0.10

112

Adenocarcinoma and papillary adenocarcinoma of stomach

2.01

0.87

1.7

1.5

0.70

1.09

nmol/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

396

1.26

0.86

1.7

1.4

1.42

1.17

nmol/l

0.66

305

Dental caries 2 and operation codes, only avohilmo

175

1227

0.88

0.86

1.7

1.6

1.30

1.26

nmol/l

0.20

136

978

Any dementia, excluding more controls

404

1.22

0.86

1.2

1.3

1.15

nmol/l

0.01

313

Other and unspecified tonsillitis

658

1.19

0.85

1.5

1.9

1.45

1.21

nmol/l

1.40

531

Palmar fascial fibromatosis [Dupuytren]

273

1.32

0.85

1.3

1.26

1.23

nmol/l

0.05

208

Pollen allergy

305

1.30

0.84

2.1

1.78

1.38

nmol/l

1.10

254

Alzheimer’s disease, wide definition

298

0.73

0.84

1.0

1.3

1.34

1.15

nmol/l

0.40

222

Other specified/unspecified bacterial intestinal infections

104

1.54

0.84

1.6

1.4

1.06

1.20

nmol/l

0.31

Allergic purpura

1.78

0.84

1.1

1.6

1.29

1.15

nmol/l

—

Phlebitis and thrombophlebitis (not including DVT)

442

1.25

0.84

1.2

1.4

1.51

1.23

nmol/l

0.65

349

Recurring oral aphthae, including avohilmo

239

1.34

0.84

1.2

1.5

1.63

1.20

nmol/l

0.73

186

Vasomotor and allergic rhinitis

759

1.18

0.83

1.9

1.7

1.44

1.26

nmol/l

0.71

609

Abrasion of teeth

437

1.21

0.83

1.8

1.5

1.05

1.19

nmol/l

0.62

362

Benign neoplasm: Skin of other and unspecified parts of face

188

1.39

0.82

1.4

1.3

0.75

1.15

nmol/l

1.82

146

Benign neoplasm: Skin of other and unspecified parts of face

188

1.39

0.82

1.4

1.3

0.75

1.26

nmol/l

2.52

146

Amblyopia ex anopsia

1.70

0.82

1.6

1.7

1.22

1.13

nmol/l

—

Basal cell carcinoma, including avohilmo

109

996

0.86

0.82

1.2

1.3

1.04

1.22

nmol/l

1.30

755

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

1.88

0.82

1.7

1.5

0.70

1.22

nmol/l

—

False labour

322

1.23

0.81

2.6

2.0

1.34

1.43

nmol/l

0.26

271

Right hemicolectomy

1.55

0.81

1.2

1.4

1.28

1.13

nmol/l

0.27

Use of memantine

316

1.27

0.81

1.2

1.3

1.25

1.15

nmol/l

0.27

237

Use of other anti-dementia drugs

316

1.27

0.81

1.2

1.3

1.25

1.15

nmol/l

0.27

237

Pain in thoracic spine

267

1.31

0.80

1.6

1.7

1.29

1.33

nmol/l

0.09

201

Basal cell carcinoma

106

979

0.86

0.79

1.2

1.3

1.05

1.21

nmol/l

1.11

742

Malignant neoplasm of tonsil

0.00

0.79

0.0

1.8

—

1.11

—

Laparoscopic left hemicolectomy

0.00

0.79

0.0

1.6

—

0.97

—

Benign neoplasm: Brain, supratentorial

0.00

0.79

0.0

1.6

—

1.13

—

Malignant neoplasm

266

1434

1.10

0.79

1.4

1.6

1.08

1.27

nmol/l

2.16

196

1130

Benign neoplasm: Brain, supratentorial

0.00

0.79

0.0

1.6

—

1.11

—

Carbimazole or st.post thyroidectomy, condition for graves disease

392

1.25

0.79

1.6

1.5

1.43

1.29

nmol/l

0.42

301

Mixed conductive and sensorineural hearing loss

233

1.33

0.79

1.3

1.20

1.22

nmol/l

0.04

177

Osteoporosis

408

1.24

0.78

1.7

1.3

1.02

1.14

nmol/l

0.46

307

Dementia

495

1.19

0.78

1.2

1.3

1.13

nmol/l

0.01

374

Malignant neoplasm of oropharynx

0.00

0.78

0.0

1.7

—

1.13

—

Congenital malformations of great arteries

0.00

0.78

0.0

1.9

—

0.81

—

Persons with potential health hazards related to communicable diseases

787

0.83

0.78

1.6

2.0

1.13

1.29

nmol/l

0.68

633

Need for other prophylactic measures

0.51

0.78

1.2

1.4

1.56

1.26

nmol/l

—

Congenital malformations of the nervous system

0.00

0.76

0.0

2.0

—

1.00

—

Other and unspecified injuries of ankle and foot

1.70

0.76

1.2

1.6

1.71

1.07

nmol/l

—

Benign neoplasm: Transverse colon

183

1.37

0.75

1.2

1.3

1.08

1.21

nmol/l

0.36

140

L01XE Protein kinase inhibitors

1.52

0.75

1.1

1.3

1.14

1.11

nmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

103

817

0.86

0.75

1.2

1.4

0.98

1.25

nmol/l

2.47

622

Covid-19 suspected case

393

0.76

0.75

2.5

1.8

1.64

1.31

nmol/l

0.62

309

Primary gonarthrosis, bilateral

125

958

1.14

0.75

1.6

1.3

1.36

1.19

nmol/l

0.93

745

Correction of physiology of bite - demanding therapy visit

124

1.45

0.75

1.8

1.4

1.02

1.32

nmol/l

0.87

Lung cancer and mesothelioma

278

0.74

1.2

1.3

1.41

1.16

nmol/l

0.42

208

Misadventures to patients during surgical and medical care

253

1.31

0.74

1.5

1.3

1.11

1.25

nmol/l

0.30

197

Abnormalities of gait and mobility

201

1.35

0.74

1.9

1.4

1.03

1.16

nmol/l

0.34

154

In situ neoplasms

656

1.18

0.74

1.2

1.6

1.07

1.27

nmol/l

1.27

506

Arthropathic psoriasis

210

1.34

0.73

1.5

1.4

1.75

1.15

nmol/l

1.31

159

Polypectomy (DHB20)

134

0.60

0.73

1.4

0.78

1.18

nmol/l

—

102

Malignant neoplasm of breast, HER-positive

604

0.82

0.73

1.2

1.5

1.52

1.22

nmol/l

1.19

477

Other psoriatic arthropathies

193

1.35

0.73

1.7

1.4

1.42

1.23

nmol/l

0.32

151

Persons encountering health services in circumstances related to reproduction

132

1014

0.88

0.73

1.6

1.41

1.22

nmol/l

1.28

107

808

Vascular dementia (subcortical)

2.00

0.72

1.6

1.7

0.43

0.84

nmol/l

—

Blepharochalasis

561

1.20

0.72

1.3

1.4

0.99

1.22

nmol/l

1.39

428

Any dementia

439

1.19

0.72

1.3

1.15

1.16

nmol/l

0.03

332

Other specified disorders of external ear

1.62

0.71

1.4

1.01

1.10

nmol/l

—

Pedal cyclist injured in other and unspecified transport accidents

211

1.33

0.71

1.7

1.5

1.60

1.20

nmol/l

0.58

166

Crushing injury of wrist and hand

1.93

0.71

1.2

1.5

0.82

1.16

nmol/l

—

Toxic effect of carbon monoxide

1.93

0.70

1.4

1.6

1.14

1.02

nmol/l

—

Other maltreatment syndromes

1.56

0.70

1.3

1.5

1.43

1.21

nmol/l

—

Other and unspecified visual disturbances

169

1.36

0.69

1.2

1.4

1.36

1.23

nmol/l

0.20

137

Seropositive rheumatoid arthritis, strict definition

283

1.27

0.69

1.3

1.4

1.47

1.25

nmol/l

0.43

222

Medicines for HER+ breast cancer

635

0.83

0.69

1.3

1.5

1.53

1.22

nmol/l

1.36

502

L04AC Interleukin inhibitors

1.53

0.69

1.5

1.23

1.27

nmol/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

108

741

1.15

0.69

1.8

1.9

1.41

1.32

nmol/l

0.33

598

Other embolism and thrombosis

239

1.30

0.69

1.3

1.63

1.17

nmol/l

0.77

186

Alzheimer’s disease (Late onset), excluding more controls

106

1.38

0.68

1.0

1.2

1.44

1.13

nmol/l

0.60

Thyrotoxicosis, other and/or unspecified

346

1.24

0.68

1.8

1.6

1.18

1.34

nmol/l

0.45

270

Malnutrition

1.86

0.68

1.2

1.6

1.24

0.81

nmol/l

—

Tinnitus

473

1.21

0.68

1.5

1.4

1.16

1.25

nmol/l

0.23

370

Other articular cartilage disorders

1.67

0.68

1.6

1.2

0.75

1.34

nmol/l

—

Infectious mononucleosis

144

1.39

0.67

2.1

2.2

1.07

1.48

nmol/l

1.27

116

Invasive ventilation

119

0.59

0.67

1.6

1.4

1.35

1.11

nmol/l

—

Tuberculosis, IBD comorbidity

119

0.59

0.67

1.4

1.3

0.76

1.08

nmol/l

—

Tuberculosis, wide

119

0.59

0.67

1.4

1.3

0.76

1.09

nmol/l

—

Excessive attrition of teeth

105

496

1.15

0.67

1.8

1.7

1.29

1.24

nmol/l

0.18

413

Oral leukoplakia and related diseases, including avohilmo

153

1.37

0.67

1.1

1.4

1.75

1.26

nmol/l

0.68

116

Respiratory tuberculosis, confirmed and not-confirmed

0.54

0.67

1.4

0.77

1.08

nmol/l

—

Respiratory tuberculosis

0.54

0.67

1.4

0.77

1.08

nmol/l

—

Artificial joint operation, meniscal resection

261

1596

1.09

0.66

1.5

1.4

1.32

1.22

nmol/l

0.80

197

1251

Spontaneous abortion

586

1.15

0.66

1.6

1.9

1.28

1.32

nmol/l

0.12

472

Carcinoma in situ of skin of other and unspecified parts of face

111

1.44

0.66

1.2

1.3

0.98

1.02

nmol/l

0.07

Triptan medication for migraine, min. 3 purchases

109

977

0.88

0.65

2.3

1.8

1.33

1.31

nmol/l

0.07

787

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

260

1.27

0.63

1.9

2.0

1.57

1.39

nmol/l

0.31

211

Malignant neoplasm of skin

125

1057

0.89

0.63

1.3

1.06

1.24

nmol/l

1.41

804

Pedal cyclist injured in transport accident

432

1.20

0.63

1.5

1.7

1.42

1.22

nmol/l

0.41

339

Restless leg syndrome

216

1.30

0.63

1.5

1.3

1.38

1.19

nmol/l

0.25

168

Atopic dermatitis

138

1053

1.12

0.63

2.1

1.8

1.32

1.26

nmol/l

0.28

109

848

Orchitis and epididymitis

164

1.34

0.62

1.2

1.3

0.89

1.21

nmol/l

1.19

128

Appendectomy

145

1551

0.90

0.62

1.8

1.6

1.35

1.24

nmol/l

0.67

113

1232

Other malignant neoplasms of skin (=non-melanoma skin cancer)

106

947

0.88

0.61

1.2

1.3

1.04

1.23

nmol/l

1.33

721

Acute nasopharyngitis (common cold)

296

1.24

0.61

1.4

1.5

1.08

1.14

nmol/l

0.20

237

Obstructed labour due to maternal pelvic abnormality

253

1.27

0.60

1.7

1.22

1.28

nmol/l

0.10

205

Coxarthrosis [arthrosis of hip](FG)

141

915

1.11

0.60

1.3

1.13

1.18

nmol/l

0.25

101

709

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

262

1430

1.08

0.60

1.4

1.6

1.10

1.27

nmol/l

1.79

196

1129

Malignant neoplasm, wide definition for exclusion

262

1430

1.08

0.60

1.4

1.6

1.10

1.27

nmol/l

1.79

196

1129

Other complications of labour and delivery, not elsewhere classified

132

0.66

0.60

3.1

2.3

1.25

1.59

nmol/l

—

111

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

262

1430

1.08

0.60

1.4

1.6

1.10

1.27

nmol/l

1.79

196

1129

Actinic keratosis

660

0.85

0.60

1.1

1.3

1.13

1.18

nmol/l

0.15

496

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

0.00

0.60

0.0

2.1

—

0.95

—

Cardiomyopathies, Primary/intrinsic

227

1.28

0.59

1.4

1.3

1.73

1.15

nmol/l

1.10

164

Melanoma in situ of trunk

0.00

0.59

0.0

1.6

—

1.03

—

Abnormal findings on diagnostic imaging of breast

0.00

0.59

0.0

1.8

—

1.01

—

Sequelae of infectious and parasitic diseases

131

1.38

0.59

1.6

1.4

1.64

1.29

nmol/l

0.67

102

Injury of other and unspecified intrathoracic organs

114

1.41

0.58

1.2

1.3

1.15

1.18

nmol/l

0.03

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

484

0.84

0.58

1.2

1.5

1.52

1.27

nmol/l

0.88

389

Female infertility, tubal origin

1.57

0.58

2.1

1.6

1.13

1.20

nmol/l

—

Pregnancy examination and test

158

1.27

0.57

1.7

2.0

1.44

1.43

nmol/l

0.01

132

Voice disturbances

511

1.18

0.57

2.0

1.5

1.25

1.26

nmol/l

0.01

397

Dental caries 1 and operation codes, only avohilmo

334

1.16

0.57

1.5

1.36

1.23

nmol/l

0.40

255

Rheumatoid arthritis

566

1.16

0.56

1.5

1.4

1.37

1.16

nmol/l

0.89

455

Hallux valgus (acquired)

470

1.16

0.56

1.6

1.4

1.16

1.13

nmol/l

0.10

382

Carcinoma in situ of skin of other and unspecified parts of face

115

1.39

0.56

1.2

1.3

0.98

1.13

nmol/l

0.29

Papillary adenocarcinoma of thyroid gland

0.57

0.56

1.0

1.5

1.14

1.30

nmol/l

—

Alzheimer’s disease (Late onset)

274

0.78

0.56

1.0

1.3

1.41

1.15

nmol/l

0.59

204

Peritonsillar abscess

420

1.19

0.56

2.0

1.7

1.35

1.22

nmol/l

0.37

335

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

136

1004

1.11

0.53

1.8

1.7

1.38

1.28

nmol/l

0.42

112

796

Chondropathies

295

1.22

0.52

1.7

1.6

1.34

1.26

nmol/l

0.18

229

Contact with heat and hot substances

1.45

0.51

1.9

1.5

1.20

1.21

nmol/l

—

Ectopic pregnancy

304

0.79

0.51

2.3

1.9

1.33

1.30

nmol/l

0.04

254

Anomalies of dental arch relationship, including avohilmo

298

1.21

0.51

1.7

1.8

1.11

1.40

nmol/l

1.36

237

Other skin changes

305

1.21

0.51

1.5

1.3

1.29

1.23

nmol/l

0.13

236

Congenital malformations of eye, ear, face and neck

109

1.38

0.50

1.3

1.9

0.73

1.33

nmol/l

—

Non-follicular lymphoma, hilmo, excluding all cancers

168

0.71

0.50

1.5

1.3

1.28

1.22

nmol/l

—

128

L04AX Other immunosuppressants

140

1275

1.10

0.50

1.4

1.6

1.31

1.23

nmol/l

0.35

109

1001

Carcinoma in situ of skin

118

1.36

0.50

1.3

1.03

1.02

nmol/l

0.01

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

297

1.21

0.50

1.4

1.20

1.24

nmol/l

0.10

232

Spondyloarthritis

343

1.20

0.49

1.5

1.25

nmol/l

0.00

264

Cardiomyopathy (excluding other)

234

1.24

0.49

1.4

1.3

1.73

1.16

nmol/l

1.05

171

Migraine with aura

371

1.19

0.49

1.9

1.68

1.26

nmol/l

1.30

304

Localized swelling, mass and lump of skin and subcutaneous tissue

651

1.14

0.49

1.4

1.5

1.09

1.23

nmol/l

0.90

516

Dysplasia of cervi uteri

308

1.18

0.48

1.7

1.9

1.09

1.25

nmol/l

0.45

247

Postpartum hemorraghe, all women as controls

416

1.17

0.48

3.5

2.1

1.70

1.34

nmol/l

1.23

349

Special screening examination for infectious and parasitic diseases

277

1.19

0.48

3.4

1.9

1.77

1.25

nmol/l

1.36

237

Cardiomyopathy

335

1.19

0.48

1.3

1.58

1.18

nmol/l

0.90

250

Crohn's disease NAS

119

1.35

0.48

1.1

1.4

1.16

1.30

nmol/l

0.36

100

Other disorders of the genitourinary system

208

1.25

0.47

1.5

1.4

1.01

1.24

nmol/l

0.69

158

Disorders of breast

102

850

1.11

0.47

1.9

1.7

1.34

1.30

nmol/l

0.13

678

Idiopathic thrombocytopenic purpura

1.46

0.47

2.0

1.5

1.52

1.17

nmol/l

—

Temporomandibular joint disorders, including avohilmo

823

1.12

0.46

2.1

1.8

1.18

1.29

nmol/l

0.48

663

Other hammer toe(s) (acquired)

281

1.20

0.46

1.3

1.34

1.05

nmol/l

0.83

215

Injury of muscle and tendon at lower leg level

291

1.20

0.46

1.3

1.5

0.84

1.18

nmol/l

2.27

229

Pneumothorax

120

1.34

0.46

1.1

1.4

1.47

1.12

nmol/l

0.51

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

278

0.80

0.45

2.3

1.7

1.32

1.26

nmol/l

0.06

216

Injuries to the elbow and forearm

172

1438

1.08

0.45

1.7

1.6

1.29

1.24

nmol/l

0.22

131

1134

Fracture of femur

410

1.16

0.45

1.2

1.3

1.02

1.18

nmol/l

0.69

304

Other disorders of bladder

219

1.23

0.45

2.1

1.3

1.25

1.18

nmol/l

0.08

169

Female infertility, cervigal, vaginal, other or unspecified origin

319

1.15

0.44

2.1

1.9

1.72

1.25

nmol/l

1.52

255

Carcinoma in situ of skin

121

1.32

0.44

1.3

1.03

1.15

nmol/l

0.26

Abnormal involuntary movements

238

1.22

0.44

1.4

1.04

1.23

nmol/l

0.63

182

Postpartum hemorraghe, parous women as controls

370

1.16

0.43

3.5

2.2

1.70

1.33

nmol/l

1.25

315

Non-allergic asthma (mode), excluding more controls

309

1.19

0.43

1.4

1.6

1.18

nmol/l

0.01

241

Unspecific neurodegenerative disorder

466

1.12

0.42

1.2

1.3

1.15

1.13

nmol/l

0.05

354

Anti-inflammatory and antirheumatic products, non-steroids

353

1.13

0.42

1.5

1.29

1.16

nmol/l

0.50

286

Contact with machinery

221

1.22

0.42

1.1

1.3

1.30

1.12

nmol/l

0.41

170

Hydrocele

221

1.22

0.42

1.2

1.3

1.26

1.21

nmol/l

0.10

170

Obstructed labour due to malposition and malpresentation of fetus

321

1.17

0.41

1.7

2.0

1.13

1.39

nmol/l

1.02

267

All dysplastic lesions of the vulva

1.43

0.41

1.6

1.25

1.38

nmol/l

—

Acute laryngitis and tracheitis

191

1.24

0.41

1.6

2.2

1.56

1.29

nmol/l

0.55

158

Maternal care for cervical incompetence

1.38

0.41

2.0

1.6

0.98

1.40

nmol/l

—

Myocardial infarction, with ST-elevation

332

1.18

0.41

1.7

1.3

1.38

1.12

nmol/l

0.46

249

Liposarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

2.1

—

1.15

—

Seminoma of testis

0.00

0.41

0.0

1.1

—

1.25

—

Sequelae of other and unspecified infectious and parasitic diseases

105

1.34

0.41

1.7

1.5

1.91

1.31

nmol/l

—

Primary open-angle glaucoma

552

1.13

0.41

1.5

1.3

1.15

1.18

nmol/l

0.04

425

Seminoma of testis, excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.3

—

1.34

—

Other and unspecified haemorrhagic conditions

0.00

0.40

0.0

1.9

—

0.97

—

Seropositive rheumatoid arthritis, wide

520

1.14

0.40

1.3

1.4

1.43

1.23

nmol/l

0.61

404

Benign neoplasm: Caecum

168

1.25

0.40

1.4

1.3

0.93

1.13

nmol/l

0.51

129

Benign neoplasm: Connective and other soft tissue, unspecified

0.00

0.40

0.0

1.8

—

1.10

—

Aphakia

0.00

0.40

0.0

1.5

—

1.47

—

Tuberculosis

103

0.68

0.39

1.3

1.4

0.98

1.09

nmol/l

—

Nasal polyp

390

1.15

0.39

1.3

1.01

1.22

nmol/l

0.85

303

Melanoma in situ of trunk

0.00

0.39

0.0

1.8

—

0.94

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

335

0.84

0.39

1.5

1.3

1.11

1.28

nmol/l

0.43

252

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

645

1.12

0.39

1.7

1.6

1.19

1.23

nmol/l

0.10

500

Hallux rigidus

251

1.20

0.39

1.3

1.20

1.09

nmol/l

0.30

195

Injury of muscle and tendon at wrist and hand level

288

1.18

0.39

1.1

1.4

1.10

1.13

nmol/l

0.07

222

Allergic rhinitis

620

1.12

0.39

2.0

1.9

1.49

1.29

nmol/l

0.73

499

Family history of malignant neoplasm

160

1.25

0.38

1.6

1.11

1.41

nmol/l

1.05

131

Conjunctivitis

187

1525

1.07

0.38

1.8

1.7

1.33

1.25

nmol/l

0.44

145

1214

Cardiodefibrillation

810

0.90

0.38

1.3

1.35

1.16

nmol/l

0.83

614

Reimbursement for rheumatic diseases

142

1314

1.08

0.38

1.5

1.6

1.21

1.23

nmol/l

0.11

108

1034

Other/unspecified seropositive rheumatoid arthritis

514

1.13

0.37

1.3

1.4

1.43

1.23

nmol/l

0.59

401

Non-allergic asthma (mode)

314

1.17

0.37

1.4

1.6

1.18

1.20

nmol/l

0.03

242

Degenerative macular diseases

179

1.23

0.37

1.6

1.2

1.02

1.24

nmol/l

—

139

Benign neoplasm: Ascending colon

234

1.20

0.37

1.4

1.3

1.14

1.18

nmol/l

0.08

175

Volvulus

1.35

0.37

1.0

1.6

0.92

1.17

nmol/l

—

Non-follicular lymphoma

158

0.76

0.37

1.5

1.3

1.28

1.13

nmol/l

—

122

Acute appendicitis, no complications

149

1383

1.07

0.37

1.9

1.6

1.30

1.24

nmol/l

0.26

117

1106

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

1.33

0.37

1.2

1.3

1.23

1.08

nmol/l

—

Other disorders of breast

207

1.21

0.36

1.4

1.7

1.31

1.37

nmol/l

0.11

163

UC patients in KELA-register (code 208), prior to 1994

1.36

0.36

1.2

1.4

1.09

1.33

nmol/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

507

1.12

0.35

1.3

1.4

1.45

1.24

nmol/l

0.65

395

Postmenopausal atrophic vaginitis

236

1.15

0.35

1.2

1.5

1.16

1.18

nmol/l

0.04

185

Benign lipomatous neoplasm of other sites/unspecified

153

1.24

0.35

1.5

1.3

1.28

1.12

nmol/l

0.30

119

Benign lipomatous neoplasm of other sites/unspecified

153

1.24

0.35

1.5

1.3

1.28

1.18

nmol/l

0.17

115

Other strabismus

394

1.14

0.34

1.8

1.36

1.28

nmol/l

0.14

305

Other inflammation of eyelid

227

1.19

0.34

1.8

1.4

1.08

1.25

nmol/l

0.36

173

Benign neoplasm of major salivary glands

178

0.79

0.34

1.1

1.3

1.08

1.21

nmol/l

—

138

Contusion of other and unspecified parts of foot

1.34

0.34

1.5

1.9

1.05

1.39

nmol/l

0.59

L02BG Aromatase inhibitors

521

0.88

0.34

1.4

1.56

1.21

nmol/l

1.37

409

Retained placenta and membranes, without haemorrhage

200

1.20

0.33

1.5

1.7

1.03

1.34

nmol/l

0.84

162

Benign neoplasm: Rectum, anus and anal canal

387

1.14

0.33

1.2

1.3

1.23

1.19

nmol/l

0.08

295

N06DA Anticholinesterases

421

0.88

0.33

1.3

1.2

1.21

1.17

nmol/l

0.09

314

Use of anticholinesterases

421

0.88

0.33

1.3

1.2

1.21

1.17

nmol/l

0.09

314

Thyrotoxicosis

482

1.12

0.33

1.7

1.6

1.19

1.28

nmol/l

0.24

376

Crohn disease (strict definition, all UC cases excluded)

0.67

0.33

3.0

1.5

1.04

1.35

nmol/l

—

Any event in cancer register

266

1502

1.05

0.32

1.4

1.6

1.11

1.28

nmol/l

1.90

197

1186

Ankylosing spondylitis, ICD10

187

0.80

0.32

1.8

1.4

1.43

1.32

nmol/l

—

145

Alzheimer disease, including avohilmo

405

0.89

0.31

1.1

1.2

1.16

1.18

nmol/l

0.05

303

Left bundle-branch block

119

1.26

0.31

2.3

1.3

1.71

1.14

nmol/l

—

Benign neoplasm: Rectum, anus and anal canal

389

1.13

0.31

1.2

1.4

1.23

1.22

nmol/l

0.03

296

Maternal care related to the fetus and amniotic cavity and possible delivery problems

509

0.91

0.31

2.4

1.9

1.46

1.40

nmol/l

0.16

417

Abnormal spermatozoa

240

0.83

0.30

1.3

1.2

1.25

1.15

nmol/l

0.22

183

Melanocytic naevi

579

0.90

0.30

1.5

1.7

1.08

1.26

nmol/l

0.76

462

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

272

0.84

0.30

1.4

1.18

1.27

nmol/l

0.17

209

Alzheimer disease

349

0.89

0.29

1.1

1.3

1.12

1.15

nmol/l

0.07

260

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

157

1.21

0.29

1.4

1.3

1.09

1.07

nmol/l

0.03

119

Later onset COPD, excluding more controls

275

1.13

0.29

1.2

1.68

1.14

nmol/l

1.52

197

Benign neoplasm: Rectum

345

1.13

0.28

1.2

1.3

1.27

1.20

nmol/l

0.19

262

Melanocytic naevi

576

0.90

0.28

1.5

1.6

1.08

1.25

nmol/l

0.70

454

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

1.27

0.27

1.0

1.4

1.49

1.21

nmol/l

—

Other diseases of gallbladder

1.25

0.27

1.5

1.30

1.24

nmol/l

—

Benign neoplasm of major salivary glands

172

0.81

0.27

1.1

1.3

1.08

1.15

nmol/l

—

135

Allergic conjunctivitis

118

1237

0.94

0.27

2.0

1.7

1.28

1.26

nmol/l

0.10

985

Acne vulgaris

113

1.24

0.26

2.2

0.68

1.41

nmol/l

—

Later onset COPD

393

0.90

0.26

1.2

1.3

1.67

1.15

nmol/l

1.55

294

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

1.20

0.26

1.0

1.3

1.49

1.13

nmol/l

—

Alzheimer’s disease, wide definition, excluding more controls

121

1.18

0.25

1.0

1.3

1.40

1.19

nmol/l

0.33

Asthma and opportunity respiratory infection

1.20

0.25

2.7

1.2

0.76

1.14

nmol/l

—

Benign neoplasm: Rectum

349

1.12

0.25

1.2

1.4

1.27

1.23

nmol/l

0.09

267

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

234

0.85

0.24

1.4

1.3

1.08

1.22

nmol/l

0.30

175

Congenital malformations, deformations and chromosomal abnormalities

147

1336

1.05

0.24

1.8

1.7

1.30

1.23

nmol/l

0.32

121

1061

Endometriosis of pelvic peritoneum

242

1.14

0.24

1.6

1.8

0.95

1.23

nmol/l

1.18

195

Contact with nonpowered hand tool

0.70

0.24

1.0

1.4

1.77

1.19

nmol/l

—

Benign neoplasm: Stomach

171

1.17

0.23

1.3

1.53

1.16

nmol/l

0.77

133

Nontraumatic intracranial haemmorrhage

332

1.11

0.23

1.3

1.01

1.18

nmol/l

0.64

257

Exposure to smoke, fire and flames

1.28

0.23

1.6

1.00

1.05

nmol/l

—

Other appendicitis

162

1.17

0.22

1.3

1.4

1.08

1.30

nmol/l

0.49

130

Pedal cyclist injured in noncollision transport accidents

209

1.15

0.22

1.5

1.4

1.18

1.21

nmol/l

0.04

160

Benign neoplasm: Ascending colon

247

1.13

0.22

1.4

1.14

1.25

nmol/l

0.28

190

Benign neoplasm: Caecum

181

1.16

0.22

1.4

1.3

0.93

1.20

nmol/l

0.78

137

Carcinoma in situ of prostate

0.00

0.21

0.0

1.1

—

1.33

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.8

—

0.65

—

Adenomyosis (Endometriosis of uterus)

182

1.15

0.21

2.2

1.5

1.53

1.09

nmol/l

0.70

143

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

2.2

—

0.74

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

0.00

0.21

0.0

1.7

—

0.80

—

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

2.2

—

0.74

—

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

2.1

—

0.90

—

Carcinoma in situ of skin, other sites/unspecified

0.00

0.21

0.0

2.3

—

1.01

—

Other and unspecified glaucoma

104

0.77

0.21

1.3

1.4

0.75

1.10

nmol/l

—

Appendicitis, broad definition

198

1739

1.04

0.21

1.7

1.6

1.24

1.25

nmol/l

0.01

153

1381

Melanoma in situ of other and unspecified parts of face

0.00

0.21

0.0

2.1

—

1.03

—

Suggestive for eosinophilic asthma

173

1.16

0.21

1.4

1.3

1.07

1.21

nmol/l

0.26

126

Benign neoplasm: Stomach

173

1.16

0.20

1.3

1.4

1.53

1.22

nmol/l

0.61

134

Delivery

416

1.07

0.20

1.7

1.6

1.32

1.33

nmol/l

0.05

328

Skin changes due to chronic exposure to nonionizing radiation

680

0.93

0.20

1.1

1.3

1.16

1.17

nmol/l

0.04

510

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.20

0.0

2.0

—

0.76

—

Single spontaneous delivery

414

1.07

0.20

1.9

1.6

1.37

1.33

nmol/l

0.11

327

Focal epilepsy, mode (most common among epilepsy diagnosis)

345

1.10

0.20

1.7

1.5

1.09

1.19

nmol/l

0.32

265

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

1.23

0.20

2.2

1.5

0.83

1.10

nmol/l

—

Impacted teeth

272

0.89

0.20

1.5

2.3

0.84

1.40

nmol/l

3.21

230

L01XX Other antineoplastic agents

1.22

0.19

1.2

1.4

1.54

1.05

nmol/l

—

143

0.84

0.18

1.2

1.3

1.13

1.09

nmol/l

—

108

Diseases of appendix

199

1749

1.04

0.18

1.7

1.6

1.25

nmol/l

0.01

154

1387

Colorectal adenocarcinoma

357

1.09

0.18

1.2

1.3

1.36

1.17

nmol/l

0.55

269

Pedestrian injured in collision with pedal cycle

1.21

0.18

2.0

1.4

0.88

1.12

nmol/l

—

Other specified/unspecified systemic involvement of connective tissue

100

1.20

0.18

1.3

1.4

1.47

1.25

nmol/l

0.28

Pleural effusion

271

1.11

0.18

1.3

1.17

1.14

nmol/l

0.05

202

Malignant neoplasm of colon

252

1.11

0.17

1.1

1.3

1.33

1.16

nmol/l

0.37

188

Colorectal cancer

435

1.08

0.17

1.2

1.3

1.23

1.17

nmol/l

0.15

329

Degenerative diseases of the nervous system

413

0.93

0.17

1.4

1.3

1.13

1.16

nmol/l

0.09

308

Other congenital malformations of the digestive system

1.14

0.17

1.1

1.6

1.00

1.13

nmol/l

—

Other pleural conditions

176

1.14

0.17

1.3

1.38

1.13

nmol/l

0.35

130

Sulfasalazine

620

1.06

0.17

1.5

1.6

1.20

1.24

nmol/l

0.11

488

Benign neoplasm: Rectosigmoid junction

0.75

0.17

1.0

1.4

0.68

1.11

nmol/l

—

Benign neoplasm: Rectosigmoid junction

0.75

0.17

1.0

1.4

0.68

1.20

nmol/l

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

359

1.09

0.16

1.3

1.21

1.20

nmol/l

0.01

272

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

224

1.11

0.16

1.2

1.3

1.25

1.20

nmol/l

0.09

163

Primary_lymphoid and hematopoietic malignant neoplasms

466

1.07

0.16

1.8

1.3

1.07

1.21

nmol/l

0.51

358

725

0.95

0.15

1.2

1.3

1.18

1.17

nmol/l

0.02

545

Oxicams

309

1.07

0.15

1.5

1.4

1.27

1.21

nmol/l

0.15

249

Other diseases of pericardium

0.79

0.15

1.7

1.4

1.67

1.10

nmol/l

—

Aortic valve malfunction, age under 60 years

197

1.12

0.15

1.5

1.3

1.15

1.19

nmol/l

0.06

149

Conductive hearing loss, unspecified

159

1.13

0.15

1.8

1.4

1.76

1.18

nmol/l

—

130

Left ventricular outflow tract obstruction (LVOTO), broad definition

207

1.11

0.15

1.5

1.4

1.09

1.16

nmol/l

0.10

159

Fenamates

200

0.91

0.14

1.8

1.6

1.19

1.15

nmol/l

0.11

162

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

479

1.06

0.14

1.5

1.3

1.14

1.20

nmol/l

0.21

363

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

114

1165

0.96

0.14

2.1

1.7

1.29

1.25

nmol/l

0.14

930

Colorectal cancer, excluding all cancers (controls excluding all cancers)

563

0.94

0.13

1.3

1.16

1.21

nmol/l

0.13

420

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

253

0.91

0.13

1.3

0.98

1.25

nmol/l

0.78

190

Endometriosis ASRM stages 3,4

412

1.07

0.13

1.9

1.8

1.14

1.35

nmol/l

0.79

332

Benign leiomyoma with endometriosis

267

1.09

0.13

1.2

1.4

1.15

1.29

nmol/l

0.27

210

Dental caries 2

196

1499

1.03

0.12

1.8

1.7

1.30

1.25

nmol/l

0.27

155

1189

Medical treatment for female infertility

343

0.93

0.12

2.7

2.3

1.40

1.43

nmol/l

0.04

292

Coxarthrosis, primary, with hip surgery

935

0.96

0.12

1.3

1.12

1.19

nmol/l

0.23

714

Primary_lymphoid and hematopoietic malignant neoplasms

473

1.06

0.11

1.8

1.4

1.07

1.20

nmol/l

0.49

357

Endometriosis ASRM stages 1,2

312

0.93

0.11

1.6

2.0

0.95

1.39

nmol/l

2.22

257

Viral haemorrhagic fevers, not elsewhere classified/unspecified

153

1.11

0.11

1.4

1.65

1.22

nmol/l

0.72

115

Malignant neoplasm of rectum

153

1.11

0.11

1.3

1.15

1.09

nmol/l

0.08

116

Vestibular neuronitis

163

1.10

0.10

1.5

1.3

1.15

1.19

nmol/l

0.07

128

Spondylopathies (FG)

260

1.08

0.10

1.5

1.37

1.25

nmol/l

0.17

200

Malignant melanoma

270

0.93

0.10

1.5

1.3

1.07

1.19

nmol/l

0.25

208

Dental caries 2 and operation codes

191

1482

1.02

0.10

1.7

1.30

1.25

nmol/l

0.28

151

1177

Cardiomyopathy, other and unspecified

146

0.89

0.10

1.2

1.3

1.01

1.15

nmol/l

—

110

Acne

144

1.11

0.10

2.1

0.67

1.39

nmol/l

3.37

116

Primary open-angle glaucoma, strict

475

1.05

0.10

1.6

1.3

1.24

1.15

nmol/l

0.17

360

Adenocarcinoma and papilloma adenocarcinoma of rectum

154

1.10

0.10

1.4

1.3

1.17

1.05

nmol/l

0.19

116

Rheumatoid arthritis, including avohilmo

799

0.96

0.10

1.5

1.39

1.20

nmol/l

0.73

632

Alzheimer’s disease (Atypical or mixed)

114

0.87

0.10

1.3

1.14

0.99

nmol/l

—

Benign neoplasm: Sigmoid colon

349

1.06

0.10

1.5

1.3

1.52

1.19

nmol/l

0.79

267

Disorders of eyelid in diseases classified elsewhere

1.09

0.09

1.0

1.7

1.42

1.21

nmol/l

—

Use of rivastigmine

193

1.09

0.09

1.2

1.3

1.31

1.04

nmol/l

0.70

145

LSIL lesion of the vulva

1.04

0.09

1.2

1.8

1.24

1.25

nmol/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.04

0.09

1.0

1.7

2.02

1.22

nmol/l

—

Benign neoplasm: Sigmoid colon

350

1.06

0.09

1.5

1.4

1.52

1.23

nmol/l

0.67

271

Coxarthrosis, primary

131

1166

0.97

0.09

1.3

1.14

1.24

nmol/l

0.49

893

Pericarditis

1.09

0.09

1.2

1.4

0.96

1.19

nmol/l

—

Acute bronchiolitis

0.83

0.08

1.6

2.4

0.64

1.32

nmol/l

—

Parkinson's disease, including avohilmo

267

0.94

0.08

1.7

1.2

1.18

1.17

nmol/l

0.02

198

0.80

0.08

1.6

1.4

0.97

1.06

nmol/l

—

Subacute thyroiditis

0.79

0.08

1.8

1.5

1.37

1.39

nmol/l

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

371

1.05

0.08

1.2

1.3

1.36

1.20

nmol/l

0.44

277

Use of donepezil

276

0.94

0.08

1.3

1.2

1.21

1.12

nmol/l

0.17

205

Unspecified privation

195

1.08

0.08

1.4

1.06

1.23

nmol/l

0.44

154

Squamous cell neoplasms and carcinomas of the skin

195

1.08

0.08

1.1

1.3

0.86

1.13

nmol/l

0.75

141

Delivery, wide proxy

323

1.04

0.07

1.9

1.6

1.34

1.31

nmol/l

0.07

256

Other (seronegative) rheumatoid arthritis, wide

357

0.95

0.07

1.7

1.4

1.11

1.18

nmol/l

0.21

272

Malignant melanoma of skin

204

0.93

0.07

1.5

1.3

1.17

1.20

nmol/l

—

157

Dementia in Alzheimer disease

209

0.94

0.06

1.2

1.3

1.10

1.11

nmol/l

0.01

158

Contraceptive management

106

728

1.02

0.06

1.9

1.7

1.39

1.25

nmol/l

0.81

579

Crohn disease (strict definition, require KELA, min 2 HDR)

104

0.86

0.06

2.3

1.6

1.04

1.31

nmol/l

—

Crohn disease (strict definition, require KELA)

105

0.86

0.06

2.3

1.6

1.04

1.31

nmol/l

—

Pregnancy, childbirth and the puerperium

278

1.04

0.06

2.0

1.6

1.28

1.29

nmol/l

0.02

218

Dermatographic urticaria

111

0.90

0.06

2.4

1.5

0.94

1.33

nmol/l

—

Other/unspecified rheumatoid arthritis

223

0.94

0.06

1.4

0.97

1.17

nmol/l

0.51

173

Retinal breaks without detachment

267

1.05

0.05

1.7

1.3

1.15

1.26

nmol/l

0.19

207

Superficial injury of shoulder and upper arm

199

1.06

0.04

1.5

1.4

1.36

1.21

nmol/l

0.19

152

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

180

0.94

0.04

1.4

1.3

1.17

1.18

nmol/l

0.01

137

Vasomotor rhinitis (mode)

139

0.93

0.03

1.9

1.4

1.19

1.24

nmol/l

—

112

Nontoxic multinodular goitre

351

0.97

0.03

1.4

1.3

1.22

1.25

nmol/l

0.06

270

Fracture of forearm

117

1081

1.01

0.03

1.7

1.6

1.43

1.22

nmol/l

0.82

851

Maternal care for known or suspected abnormality of pelvic organs

289

1.03

0.03

2.5

2.0

1.17

1.37

nmol/l

0.75

243

Retinal detachment with retinal break

211

1.04

0.03

1.4

1.2

1.08

1.24

nmol/l

0.41

163

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

201

1.04

0.03

1.1

1.3

0.86

1.17

nmol/l

0.92

151

Secondary uncertain malignant neoplasm

219

0.96

0.03

1.6

1.3

1.21

1.18

nmol/l

0.05

168

Dental caries 2, only avohilmo

189

1478

1.01

0.02

1.8

1.7

1.30

1.25

nmol/l

0.25

149

1175

Scoliosis

132

1.06

0.02

1.0

2.0

1.07

1.27

nmol/l

—

110

Benign leiomyoma with endometriosis

281

1.03

0.02

1.2

1.5

1.15

1.27

nmol/l

0.22

227

Other abnormal products of conception

393

0.98

0.02

1.9

2.2

1.38

1.36

nmol/l

0.04

324

Nontoxic goitre/thyroid nodule

559

0.98

0.02

1.7

1.4

1.11

1.23

nmol/l

0.39

427

Mixed connective tissue disease

113

1.06

0.01

1.9

1.5

1.54

1.24

nmol/l

0.42

Acute appendicitis

179

1681

1.00

0.01

1.8

1.6

1.26

1.25

nmol/l

0.04

142

1336

Ankylosing spondylitis

156

0.96

0.00

1.8

1.6

1.43

1.22

nmol/l

—

120

Bacterial, viral and other infectious agents

176

0.97

0.00

1.8

1.5

1.32

1.37

nmol/l

0.07

138

Biological medication for rheuma

306

1.01

0.00

1.5

1.7

1.22

1.32

nmol/l

0.27

238

Embedded and impacted teeth

392

1.00

0.00

1.8

2.1

1.03

1.39

nmol/l

1.46

322

Oter anti-inflammatory and antirheumatic agents, non-steroids

281

1.01

0.00

1.6

1.4

1.16

1.23

nmol/l

0.25

226

Overexertion and strenuous or repetitive movements

198

1.01

0.00

1.4

0.89

1.26

nmol/l

1.22

154

Methotrexate

275

1.02

0.00

1.5

1.4

1.16

1.31

nmol/l

0.34

214

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

118

1.02

0.00

2.0

1.6

1.03

1.30

nmol/l

0.83

Arthropod-borne viral fevers and viral haemorrhagic fevers

189

1.01

0.00

1.4

1.61

1.21

nmol/l

0.73

139

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

185

1.03

0.00

1.4

1.3

1.09

1.18

nmol/l

0.15

141

Transient global amnesia

157

1.02

0.00

1.3

0.83

1.13

nmol/l

—

122

Use of peginterferon beta-1a

0.00

0.0

2.4

—

0.91

—

Non-Hodgkin lymphoma, all

0.96

0.00

1.0

1.3

1.34

0.96

nmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

0.92

0.00

3.6

2.3

1.69

1.59

nmol/l

—

Benign neoplasm of other and unspecified sites

0.98

0.00

1.2

1.5

1.09

1.16

nmol/l

—

Epidural haemorrhage

0.00

0.0

2.4

—

1.10

—

Fall involving playground equipment

0.00

0.0

2.8

—

0.42

—

Other and unspecified disorders of binocular movement

0.00

0.0

1.4

—

1.09

—

Female infertility, uterine origin

0.00

0.0

2.7

—

1.45

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

0.00

0.0

1.0

—

0.82

—

Hair colour and hair shaft abnormalities

0.00

0.0

2.4

—

1.22

—

Complications of anaesthesia during labour and delivery

0.00

0.0

2.4

—

1.39

—

Neuralgic amyotrophy

0.00

0.0

1.2

—

0.49

—

Other fibroblastic disorders

0.00

0.0

2.3

—

0.62

—

Femoral hernia

0.96

0.00

1.6

1.4

1.17

1.18

nmol/l

—

Carcinoma in situ of breast, intraductal

140

1.00

0.00

1.2

1.5

1.00

1.24

nmol/l

—

115

Benign neoplasm of other and unspecified sites

0.93

0.00

1.2

1.5

1.09

1.12

nmol/l

—

Carcinoma in situ of breast, intraductal

140

1.00

0.00

1.2

1.5

1.00

1.25

nmol/l

—

109

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

0.96

0.00

3.6

2.4

1.69

1.61

nmol/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

C peptide [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS